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SUMMARY 
 
 
Yessotoxins (YTXs) are ladder-shaped polycyclic ether toxins, structurally related to 
brevetoxins and ciguatoxins (Ciminiello and Fattorusso, 2008). The parent compound of this 
class, yessotoxin, has been initially isolated from the scallop Patinopecten yessoensis (Murata 
et al., 1987). Only later their natural source has been identified in the phytoplanktonic 
dinoflagellates Protoceratium reticulatum (= Gonyaulax grindley) (Satake et al., 1997), 
Lingulodinium polyedrum (= Gonyaulax polyedra) (Tubaro et al., 1998; Paz et al., 2004) and 
Gonyaulax spinifera (Rhodes et al., 2006). When environmental conditions promote the 
growth of these species, their toxins accumulate in edible tissues of filter feeding shellfish 
exposed to these dinoflagellates, thus entering in the food chain. No human toxicity has been 
reported for YTXs, although YTXs contaminated-shellfish were worldwide recorded, thus, 
yessotoxin toxicological potential is still unknown.  
Toxicological in vivo studies revealed high toxicity in mice after intraperitoneal 
administration (LD50~μg/Kg), whilst very low toxicity (no lethality) was found after acute or 
repeated oral administration. Both routes are associated with clear evidence of ultrastructural 
cardiac alteration in rodent cardiac muscle, soon after toxin administration (Aune et al., 2002; 
Tubaro et al., 2003). Notwithstanding many in vitro studies highlighted numerous 
intracellular targets, YTX mechanism of action is unclear and the effects on the cardiac 
functional properties remain unknown. This study was performed on neonatal rat 
cardiomyocytes to study toxin effects on various fundamental aspects of cardiac muscle cells 
activity: cell beating, intracellular Ca
2+ 
and cAMP levels, cell vitality, mitochondrial membrane 
potential and type of cell death occurrence.  
Results showed a time- and concentration-dependent reduction in the beating frequency (0.3 μM 
YTX, 1 h; p<0.05), neither associated to the uncoupling between the membrane electrical activity 
and Ca
2+
 release from intracellular stores nor to the impairment of the mechanisms controlling the 
Ca
2+
 homeostasis, nor to altered intracellular cyclic AMP levels. However, a decrease in the 
firing frequency (about 50%) occurred together with a 50% reduction of the number of 
beating cardiomyocytes. 
A time- and concentration-dependent decrease in cell viability (0.1 µM YTX; 24 h) was 
observed, that evolved in two phases: at 24 h a significant (p<0.001) increase in mitochondrial 
activity (0.0001-1 μM YTX) together with membrane hyperpolarization (0.01-1 μM YTX; 
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p<0.001) occurred, with subsequent reduced cell viability and mitochondrial depolarization 
(0.01-1 μM YTX; p<0.001) starting from 48 h. YTX effect on mitochondrial potential wasn‟t 
affected by peripheral benzodiazepine receptor ligands PK-11195 and/or 4-chloro-diazepam 
(100 nM) after 24-48 h. Increasing concentrations of YTX induced the appearance of nuclear 
apoptotic bodies in a time-dependent way (0.001-0.1 μM YTX; 5-24 h), but no caspase 
activation (0.001-0.1 μM YTX; 5-72 h). Further viability experiments showed an irreversible 
cell damage, since no recovery occurred after up to 71 h in YTX-free medium. Moreover, 1 h 
exposure to 1 μM YTX was sufficient to inhibit beating activity and to cause irreversible 
reduction of cardiac cells viability. Propidium iodide uptake experiments showed a significant 
(p<0.01) increase of necrotic cells after 24 h (0.01 µM), but not after 5 h YTX exposure.  
These results show a very cell-specific response to YTX if compared to previous studies, and 
a severe damage to in vitro cardiomyocytes. Thus, although no human intoxication due to 
YTX contamination has been reported so far, the toxicological potential of this compound 
should be better investigated. 
 
Studying this toxin is limited by its non-commercial supply: YTX needed for this experiments 
was a kind gift of Professor T. Yasumoto. 
 
  
 
 
 
INTRODUCTION 
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Yessotoxins chemical structure 
 
 
Yessotoxins (YTXs) are ladder-shaped trans-fused ether rings toxins structurally related to 
brevetoxins and ciguatoxins (Ciminiello and Fattorusso, 2008). The parent compound of this 
class, yessotoxin, has been initially isolated in Japan from the scallop Patinopecten yessoensis 
(Murata et al., 1987) and thereafter detected in mussels throughout the world. Producing 
microalgae were detected in Japan, New Zealand, Norway, Italy, Scotland, and Chile 
(Howard et al., 2009). Toxins production takes places in the phytoplanktonic dinoflagellates 
Protoceratium reticulatum (Gonyaulax grindley) (Satake et al., 1997), Lingulodinium 
polyedrum (Gonyaulax polyedra) (Tubaro et al., 1998; Paz et al., 2004) and Gonyaulax 
spinifera (Rhodes et al., 2006). When environmental conditions promote the growth of these 
species, their toxins accumulate in edible tissues of filter feeding shellfish exposed to these 
dinoflagellates, thus entering in the marine food chain up to humans. 
YTX is a disulfated polyether formed by 11 adjacent ether rings of different sizes and a 
terminal acyclic unsaturated side chain consisting of 9 carbons and 2 sulfate ethers. 
About 100 yessotoxin analogues have been reported to date from both shellfish and 
dinoflagellates microalgae, although only the structure of 36 of them have been identified and 
characterized by NMR and /or LC-MS/MS techniques (Paz et al., 2008). As it is usually the 
case for marine toxins, some yessotoxins are directly produced by dinoflagellates, most of 
which derive from P. reticulatum, while a large number of derivatives is produced by the 
shellfish metabolism and differ in the oxidation state of the molecule, including 
hydroxilations, carboxylations, desulfatations, methylations, oxidations, amidations, changes 
in the length of the carbon chain, absence of the A ring, or glycosylation (Paz et al., 2008; 
Dominguez et al., 2009). 
___  In trod uction  
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toxin R1 R2 n 
YTX =CH2 H 1 
45-hydroxyYTX =CH2 OH 1 
carboxyYTX CO2H H 1 
homoYTX =CH2 H 2 
45-hydroxihomoYTX =CH2 OH 2 
carboxyhomoYTX CO2H H 2 
 
 
Figure 1: yessotoxins and main natural derivatives  
(Miles et al., 2005). 
 
 
 
Yessotoxin exposure 
 
Yessotoxins are often co-present in shellfish contaminated with lipophilic marine toxins 
responsible of Diarrhetic Shellfish Poisoning (DSP) episodes, and bivalves extracts give 
positive results in the mouse bioassay traditionally employed to detect DSP toxins (Terao et 
al., 1990; Ogino et al., 1997). For this reasons, yessotoxins were initially included in the 
Diarrhetic Shellfish Poisoning (DSP) toxins group, but since neither in vivo diarrhea after oral 
administration (Ogino et al., 1997; Tubaro et al.,1998, 2003), nor in vitro inhibition of protein 
phosphatases (Ogino et al., 1997) occur, the European Commission classified YTX into a 
___  In trod uction  
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separately regulated phycotoxin group (Directive 2002/225/EC), then derogated by 
Regulation Nº 853/2004/EC, which was amended by Regulation 2074/2005/EC of the 
European Commission (Paz et al., 2008). 
Yessotoxin microalgae production is a worldwide phenomenon, with producing algae 
localization in Spain, United Kingdom, Italy, Ireland, Norway, United States (California, 
Florida, Washington), New Zealand, Canada, Japan, South Africa (Howard et al., 2009). 
Notwithstanding YTXs contaminated-shellfish were worldwide recorded and sometimes even 
at high concentrations up to several mg/kg (Munday et al, 2008; Paz et al, 2008) no reports of 
human poisoning induced by yessotoxins have been reported so far, thus human symptoms of 
intoxication are unknown. 
To mice, either acute or repeated oral administration of yessotoxin, homoYTX and 45-
hydroxy-homoYTX is not lethal, does not induce diarrhoea or provoke any evident symptom 
or sign of toxicity (Terao et al., 1990; Ogino et al., 1997; Munday et al., 2001; Aune et al., 
2002; Tubaro et al., 2003, 2004, 2008a; Espenes et al., 2006). This could be due to a poor 
adsorption after oral intake: Tubaro et al. (2008a) reported a mean blood concentration of 
only 3.12 ng YTX equivalents/ml of blood 24 hours after the last 7 days-administration (1 
mg/kg/day). 
Histopathological studies revealed ultrastructural changes only at cardiac level 40 minutes to 
24 hours after acute exposure (1-10 mg YTX/kg) (Aune et al., 2002; Tubaro et al., 2003) and 
daily repeated oral exposure to the toxin (1 and 2 mg/kg/day, for 7 days) (Tubaro et al., 
2008a). Alterations were not detected at lower doses (0.5 mg YTX/kg) (Terao et al., 1990). 
Ultrastructural alterations consist of swelling and cytoplasmic protrusions of cardiac muscle 
cells into the pericapillary space, package of rounded mitochondria and myofibrillar 
alterations (Aune et al., 2002; Tubaro et al., 2003). The cardiac tissue damage seems to be 
only temporary, since it was present 30 days after exposure (1 mg YTX/kg/day, for 7 days), 
while after 90 days a complete recovery occurred leaving no differences between control and 
YTX-treated mice were observed (Tubaro et al., 2008a). Moreover, non consecutive daily 
administration of YTX (1-5 mg YTX/kg twice a week within 21 days) resulted in no heart 
ultrastructural alteration 3 days after the last exposure (Espenes et al., 2006). 
Acute intraperitoneal injection of YTX and some analogues was lethal to mice at doses 
between 0.08-0.1 and 1 mg/kg (Terao et al., 1990; Ogino et al., 1997; Aune et al., 2002; 
Tubaro et al., 2003; Franchini et al., 2004a and b). Similarly to oral administration, toxin 
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intraperitoneal injection affect cardiac tissue with ultrastructural changes such as swelling and 
separation of  mitochondria and myofibrils (Terao et al., 1990; Aune et al., 2002).  
YTX lethal doses cause restlessness, dyspnoea, jumping (Tubaro et al., 2003), shivering, and 
cramps (Aune et al., 2002) before death. Other alterations have been observed in mice 
cerebellar Purkinje cells and thymus (Franchini et al., 2004a and b). 
Interestingly, di-desulfo-YTX showed a different target organ, by induction of mainly 
pancreas and liver alterations, with a severe fatty degeneration (300-500 µg/kg). Only a slight 
deposition of fat droplets was observed in cardiac muscle.  
Notwithstanding the toxicological potential of yessotoxins is under debate, the few 
toxicological data pose for the possible risk for human health consequent to its exposure. 
 
 
Yessotoxin in vitro effects 
 
Ion channels 
 
Voltage gated sodium channels 
 
Yessotoxin structure is very similar to brevetoxins and ciguatoxins, two neurotoxin groups 
that bind to receptor site 5 on voltage gated sodium channels increasing cell membrane 
permeability to sodium ions. Experiments performed to investigate on a common target in 
mediating YTX activity seem to rule out this hypothesis. Inoue et al. (2003) found both 
yessotoxin (1 µM) and di-desulfo yessotoxin (4.2 µM) unable to displace [
3
H] PbTx-3 from 
rat brain synaptosomes channels, indicative of no binding on sodium channel site 5. Further 
experiments showed only a very small membrane potential depolarization in BE(2)-M17 
human neuroblastoma cell line exposed to yessotoxin (1 μM) and in presence of veratridine 
no significant changes were detected, suggesting no interference of YTX on plasma 
membrane ion flux (Louzao et al., 2006). 
Moreover, YTX induced rat cerebellar neurons cell death also in presence of saxitoxin and 
nefopam, two antagonists of voltage sensitive sodium channels (Pérez-Gómez et al., 2006). 
 
Calcium channels 
 
Some evidence of a modest and possibly indirect effect of YTX on calcium movements have 
been published on mammalian and mussel cells. de la Rosa et al. (2001a) studied YTX effect 
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on Ca
2+
 homeostasis on freshly isolated human lymphocytes, founding a slight increase of 
intracellular Ca
2+
 after YTX exposure (1 µM). This effect was abolished in calcium-free 
medium and in the presence of either nifedipine, a voltage-gated L-type calcium channel 
antagonist, or SKF96365, a receptor-mediated Ca
2+
 entry inhibitor. YTX also exhibited a 
facilitatory effect on the influx of calcium induced by maitotoxin, a Ciguatera-related 
phycotoxin that activates Ca
2+
-permeable, non-selective cation channels (de la Rosa et al., 
2001b). On the other hand, YTX had an opposite, inhibitory effect in a calcium-free medium, 
reducing the Ca
2+
 influx induced by the addition of 1 mM CaCl2, and also inhibited the 
intracellular calcium increase evoked by the calcium-ATPase inhibitor thapsigargin (de la 
Rosa et al., 2001a). 
On primary cultures of rat cerebellar neurons, 1 h exposure to YTX (25 nM) induced a slight 
but significant increase of intracellular calcium content, blocked by nifedipine and verapamil 
but not by TMB-8, an intracellular calcium antagonist (Pérez-Gómez et al., 2006). 
Because of the modest increase in calcium influx, a direct interaction of YTX with voltage-
sensitive L-type calcium channels was considered unlikely, as well as the role of calcium in 
YTX-induced cell damage, since in presence of channel blockers cell death still occurred. 
YTX effect on L-type calcium voltage gated channels was also studied in the immunocytes 
from the mussel Mytilus galloprovincialis (Malagoli et al., 2006a), on which YTX (250 nM) 
doubled intracellular calcium concentration. The effect was totally abolished by verapamil, 
2‟,5‟-dideoxyadenosine, an inhibitor of adenylyl cyclase, and LY-83583, an inhibitor of 
soluble guanylyl cyclase. PKA involvement was excluded and it was thus hypothesized that 
YTX can influence both the activity of voltage-gated L-type calcium channel and cyclic 
nucleotide-gated cation channels. Recently, it has been reported that YTX (1 µM) did not alter 
the intracellular calcium transient in mouse skeletal muscle cells, but still caused a dramatic 
reduction of cell vitality (Tubaro et al., 2008b). 
 
 
Cyclic nucleotides 
 
Cyclic AMP 
 
Second messanger cyclic AMP (cAMP) involvement in YTX-induced cellular effects has 
been investigated on both human and mussel cells.  
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Experiments performed on human peripheral blood lymphocytes showed that YTX (1 µM) 
induced a dual effect on intracellular cAMP, dependent upon the presence or the absence of 
calcium in the culture medium. In the presence of extracellular Ca
2+
, YTX induced a small 
and transient (within 90 seconds) increase of cyclic AMP soon followed by a decrease 
towards control levels, whereas a sustained and consistent increase was present in Ca
2+
-free 
medium (Alfonso et al., 2003). YTX was then found to bind at least to Ca
2+
-calmodulin-
dependent PDE 1, cyclic GMP inhibited PDE 3, cyclic AMP-specific PDE 4, exonuclease 
PDE I (Alfonso et al., 2005; Pazos et al., 2006) and cGMP-stimulated phosphodiesterases 
PDE 2 together with desulfated yessotoxin (Mouri et al., 2009) but with low affinity (μM 
range).  
In mussel immunocytes, a cAMP- and calcium-dependent effect of YTX on cell shape was 
found in cells activated by N-formyl-Met-Leu-Phe (fMLP), a chemotactic agent that promotes 
cellular changes and cell motility via both cAMP and phosphatidylinositol pathways. YTX 
(250 nM) induced a cell shape shift from a rounded inactive form to an ameboid active one, 
an effect that was counteracted by adenylyl cyclase inhibitor 2‟,5‟-dideoxyadenosine and by 
verapamil. Inhibitors of protein kinase A (PKA), protein kinase C (PKC) and 
phosphoinositide 3-kinase (PI3K) (H-89, calphostin C and wortmannin, respectively), were 
ineffective (Malagoli and Ottaviani, 2004), 
 
Cyclic GMP 
 
As reported above, the only, and indirect, evidence of a role of cyclic GMP in the action of 
YTX has been obtained by Malagoli et al (2006a), on the basis of the ability of LY-83583, an 
inhibitor of soluble guanylyl cyclase, to impair YTX-induced intracellular calcium increase in 
mussel immunocytes (Malagoli et al., 2006a). 
 
 
Cytoskeleton 
 
After Franchini et al. (2004a) found by immunocytochemical technique some YTX-induced 
alterations to the cytoskeleton and the extracellular associated proteins of cerebellum Purkinje 
cells of mice intraperitoneally injected with YTX, several in vitro experiments on different 
cellular models confirmed the effect of YTX on cytoskeletal components, in particular F-actin 
and E-cadherin. 
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F-actin 
 
A significant, time-dependent decrease in F-actin filaments was found in cerebellar granule 
cell cultures after 24 and 48 h of contact (25 nM YTX) (Pérez-Gómez et al., 2006), in insect 
fat body IPLB-LdFB and mouse fibroblast NIH3T3 cell lines after 24 h, that end up after 72 h 
of treatment with the complete lost of cytoskeletal integrity (Malagoli et al., 2006b), and in rat 
L6 and mouse BC3H1 myoblast cell lines up to 48 h (100 nM YTX) (Suárez Korsnes et al., 
2007). Yessotoxin induced also the cleavage of tensin, a protein localized at the focal 
adhesion contacts that links F-actin filaments to the extracellular matrix, maybe as a 
consequence of the activation of caspase-3 (Suárez Korsnes et al., 2007). In accordance with a 
delayed effect on cytoskeleton, with respect to early events (see Suárez Korsnes et al., 
2006b), a short time of incubation (1-4 h) with YTX had no effects on F-actin levels even at 
high concentration (1 µM YTX) (Leira et al., 2003; Ares et al., 2005). 
Interestingly, 24 h of treatment (1 nM YTX) decreased F-actin levels in MCF-7 human breast 
adenocarcinoma cells, but not in Caco-2 human colon adenocarcinoma cells, indicating a 
specific cell-related phenomenon (Leira et al., 2003; Ronzitti et al., 2007). 
Recent results showed YTX (1 nM)-affected cytoskeletal F-actin organization after 12 hours 
exposure without a detectable reduction in its content but leading to changing in cell shape of 
J774 murine macrophages (Orsi et al. 2010).  
 
E-cadherin 
 
YTX also affected the degradation pathway of E-cadherin, a cell adhesion molecule expressed 
in epithelial cells that is linked to F-actin through the binding proteins β- and γ-catenins 
(Stemmler, 2008). 
Exposure of the epithelial cell line MCF-7 to YTX (0.2-1 nM) for 20 h resulted in a 
concentration-dependent accumulation of a 100 kDa E-cadherin fragment (ECRA100) (Pierotti 
et al., 2003) with an EC50 value of 0.55 nM (Ferrari et al., 2004). YTX effect was selective 
for epithelial E-cadherin, since it was induced in the epithelial cell lines human breast 
adenocarcinoma MCF-7 cells, human intestinal Caco-2 cells and Madin Darby canine kidney 
MDCK cells, but not in the rat pheochromocytoma PC12 cells, which express N-cadherin. 
Furthermore, YTX couldn‟t induce accumulation of fragments of one other member of the 
cadherin family, the K-cadherin (cadherin-6) in the three epithelial cell lines employed 
(Ronzitti et al., 2004; Ronzitti et al., 2007). Contrary to in vitro observations, a study 
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performed in vivo exposing mice to repeated oral doses (1 mg/kg/day, for 7 days) showed that 
extracts from colon, but not from lung, kidney or serum, contained a 90 kDa fragment of E-
cadherin (ECRA90), but the content was significantly higher in colon extracts from control 
mice than from YTX-treated animals (Callegari et al., 2006). 
The exact mechanism by which YTX at nanomolar concentrations affects the degradation 
pathway of E-cadherin is still unknown, but involves inhibition of its internalization and 
degradation, possibly as a consequence of an altered turnover of plasma membrane proteins 
(Callegari and Rossini, 2008). 
In accordance to inhibited endocytosis, Orsi et al. (2010) found YTX (1-10 nM) as inhibitor 
of J774 murine and mouse peritoneal macrophages phagocytosis in terms of internalization 
and phagosome maturation. 
 
Lysosomes 
 
YTX has been found to cause a time- and concentration-dependent alteration of lysosomal 
vesicles in two different cell lines, the insect fat body IPLB-LdFB and the mouse fibroblast 
NIH3T3 cells. Within 24 h of incubation with YTX (100 nM), this subcellular component was 
no more detectable, indicating that the lysosomal content had changed or had been released 
into the cytoplasm. Since this effect has been observed both in the invertebrate and in the 
vertebrate model after the same exposure time and with the same concentrations, the authors 
suggested that the involvement of lysosomes as a general mechanism of YTX action 
(Malagoli et al., 2006b). Indeed, YTX (1 nM) interferes with the disposal of the degradation 
products of E-cadherin in MCF-7 human breast adenocarcinoma cells in a manner that 
resembled that of chloroquine, a drug known for its ability to hinder the function of 
lysosomes, causing extensive cell death (Callegari and Rossini, 2008). 
 
 
Apoptosis and cell death 
 
The effects of YTX exposure on both apoptosis process and mitochondrial activity are 
perhaps the aspects that have been mostly investigated in vitro until now. 
Several authors have investigated the ability of YTX to induce apoptotic cell death and the 
results highlighted differences in toxin sensitivity among cell lines and cell line-specificity in 
biochemical responses. The first study on the apoptotosis-inducing activity of YTX was 
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performed on the BE(2)-M17 neuroblastoma cell line, where the toxin induced morphological 
and biochemical changes typical of the apoptotic process. Starting from 12 h of incubation in 
the presence of YTX (10 nM), an increase of the Annexin-V binding was found, that is 
indicative of the translocation of phosphatidyl serine from the inner to the outer leaflet of the 
plasma membrane, characteristic of apoptotic cells. YTX also induced an increase of caspase-
3 activity and a decrease of DNA content after 48 h of exposure. Only at high concentration 
(1 μM YTX) a reduction of mitochondrial membrane potential, morphological changes and 
DNA degradation after 12, 24 and 48 hours, respectively, were observed. The integrity of the 
plasma membrane was maintained throughout the whole period (up to 72 h) (Leira et al., 
2002). Similarly, caspase activation, in particular of caspase-3 and -7, and DNA 
fragmentation have been demonstrated in HeLa S3 cells exposed for 48 h to YTX (1 nM) 
(Malaguti et al., 2002), and DNA fragmentation, with condensation or fragmentation of 
chromatin, neurite fragmentation and appearance of apoptotic nuclei was observed in rat 
cerebellar neurons cultures exposed for 16 h to YTX (25 nM) (Pérez-Gómez et al., 2006). 
Caspase-3 and -9 activation, but not DNA fragmentation, was found by Suárez Korsnes et al. 
(2006a) in undifferentiated rat L6 and mouse BC3H1 skeletal muscle myoblast exposed for 
48-72 h (100 nM YTX). Cells morphology also underwent to characteristic apoptotic 
sequential changes, such as cell shrinkage and plasma membrane blebbing, with a L6 cells 
higher sensitivity to YTX than BC3H1 cells. 
On the contrary, YTX (10-100 nM) failed to induce a clear, unambiguous pro-apoptotic effect 
in both IPLB-LdFB insect fat body and NIH3T3 mouse fibroblast cells. Indeed, nuclear 
integrity was generally maintained with only a small percentage of insect cells showing DNA 
fragmentation (Malagoli et al., 2006b). Similarly, activation of caspase-3 and -7 or 
fragmentation of poly(ADP)ribose polymerase were not detected in Caco-2 and MCF-7 cells 
exposed to YTX (1 nM) (Callegari and Rossini, 2008). 
Apoptotic phosphatidylserine exposure and necrotic cells were detected in HepG2 cell line 
after 12 and >24 hours exposure to YTX (1.4 μM), respectively (Young et al., 2009).  
 
Mitochondria 
 
The involvement of mitochondrial permeability transition pore (PTP) in YTX toxic effects 
has been directly demonstrated in mitochondria isolated from livers of male Wistar rats 
(Bianchi et al., 2004). In this system, YTX acted as a potent pore opening reducing PTP 
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opening time (K50 197 nM) and leading to membrane depolarization. These effects were 
abolished by the PTP inhibitor cyclosporine A, demonstrating a direct effect of YTX on PTP. 
Notably, YTX was able to cross cell membrane and exerted a PTP-inducing effect in intact 
MH1C1 Morris Hepatoma cell line, where a concentration- and time-dependent 
depolarization of mitochondrial membrane occurred.  
The involvement of the mitochondrial pathways in YTX-induced apoptosis has been 
confirmed in rat L6 and mouse BC3H1 skeletal muscle myoblasts, on which YTX (100 nM) 
induced loss of the mitochondrial membrane potential, opening of the PTP and release of 
cytochrome c and of the pro-apoptotic factor Smac/DIABLO (Suárez Korsnes et al., 2006b). 
Transmission electron microscope analysis confirmed the occurring of biochemical changes 
concomitantly to morphological changes such as swelling of mitochondria, increased density 
of the matrix space with loss or decrease of cristae number (Suárez Korsens et al., 2006b). 
 
 
Other effects 
 
Yessotoxin-treated cells increased cytokine release such as interleukin-2 in human 
lymphocytes after 20 hours exposure to 1 μM YTX (Alfonso et al., 2003), and such as TNF-α, 
MIP-1α and MIP-2 in J774 murine macrophages after 12 hours exposure to 0.1-10 nM YTX 
(Orsi et al., 2010). 
A first proteomic analysis of YTX effects was performed by (Young et al., 2009) examining 
protein changes in HepG2 cells exposed for 3, 12.5, 18 and 24 h to YTX (1.4 μM). Results 
revealed a wide range of YTX-affected proteins, included molecular chaperones such as heat 
shock protein isoforms and protein disulphide isomerase precursors, nuclear proteins such as 
hnRNPs and lamins, the cathepsins and enzymes involved in cellular metabolism. 
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Cardiomyocytes cultures 
 
 
Neonatal rat cardiomyocytes primary cultures 
 
Since Harary and Farley first separated Wistar neonatal rat cardiomyocytes and succeeded in 
making spontaneously beating cardiomyocytes in vitro for 40 days, primary culture of 
cardiomyocytes has been widely applied in the basis cardiological research (Fu et al., 2005). 
Nowadays, the cultures of neonatal rat cardiomyocytes represent a well-established model for 
the observation and the understanding of cellular aspects of the electrophysiological, 
contractile, morphological, metabolic and molecular properties of the myocardium. A broad 
spectrum of experiments has been performed on these cultures, such as studies of contraction, 
ischemia, hypoxia, hypertrophy, cell death, toxicity and transport of drugs (Chlopcikovà et 
al., 2001; Athias et al., 2006). The advantage in doing experiments with neonatal rat 
cardiomyocytes is the lack of the influences of hemodynamic factors existing in vivo. In 
addition, in cell culture is feasible to control artificially other concomitant factors. 
Because cardiomyocytes lose their ability to proliferate shortly after birth, growth of heart 
tissue is governed by cell growth rather than by proliferation. This cardiomyocytes feature 
doesn‟t allow cell propagation and requires repetitive primary cultures for multiple 
experiments (Fu et al., 2005). Rat heart cells can be obtained from either neonatal or adult 
rats, but the former are advantageous because of their lower sensitive to the concentration of 
calcium in the medium. Moreover, phenotype of cultured neonatal rat cardiomyocytes is very 
stable whilst cells from rats older than 5 days give poor quality of cardiomyocytes 
preparation, with less active cells that lose quickly contraction ability (Chlopcikovà et al., 
2001).  
 
HL-1 cardiomyocytes 
 
HL-1 cell line was derived from AT-1 mouse atrial tumor cells obtained from transgenic mice 
in which the expression of SV40 large T antigen is cardiac-directed (Claycomb et al., 1998). 
HL-1 cells spontaneously depolarize and express the necessary ion channels required for 
generating action potentials characteristic of primary cardiomyocytes. Cells contain highly 
organized sarcomeres necessary for mediating contraction and intracellular ANF granules 
characteristic of atrial myocytes. Analysis of gene expression revealed that they exhibit an 
adult cardiomyocyte-like gene expression profile. This differentiated cardiac phenotype is 
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maintained in vitro through the addition in the media of components such as retinoic acid, 
norephinephrine, insulin and essential lipids. Nowadays HL-1 cardiomyocytes have been used 
as a model system to investigate the effect of common pathophysiological conditions such as 
hypoxia, hyperglycemia and hyperinsulinemia, electrophysiology and various cellular 
signalling pathways, apoptosis and cardiomyocytes cell cycle studies (White et al., 2004) and 
mitochondrial dynamics (Beraud et al., 2009). 
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Yessotoxin (YTX) is a food chain contaminating phycotoxin that accumulates in edible 
tissues of filter feeding shellfish exposed to toxin-producer dinoflagellates and may be 
ingested by humans through seafood consumption. Toxins production takes places in the 
phytoplanktonic dinoflagellates Protoceratium reticulatum (Gonyaulax grindley) (Satake et 
al., 1997), Lingulodinium polyedrum (Gonyaulax polyedra) (Tubaro et al., 1998; Paz et al., 
2004) and Gonyaulax spinifera (Rhodes et al., 2006). These algae have been localized in 
several countries, included Spain, United Kingdom, Italy, Ireland, Norway, United States 
(California, Florida, Washington), New Zealand, Canada, Japan, South Africa (Howard et al., 
2009), and contaminated-shellfish detection became a worldwide occurrence. No reports of 
human poisoning induced by yessotoxin have been reported so far, thus human symptoms of 
intoxication are unknown. 
In vivo toxicological studies have been performed in mice to clarify YTX toxicological 
potential. Either acute or repeated oral administration of yessotoxin is not lethal, nor provokes 
any evident symptom or sign of toxicity (Terao et al., 1990; Ogino et al., 1997; Munday et 
al., 2001; Aune et al., 2002; Tubaro et al., 2003, 2004, 2008a; Espenes et al., 2006), probably 
due to a poor adsorption after oral intake (Tubaro et al., 2008a). On the contrary, acute 
intraperitoneal injection revealed high toxicity in mice (LD50~μg/Kg) (Terao et al., 1990; 
Ogino et al., 1997; Aune et al., 2002; Tubaro et al., 2003; Franchini et al., 2004a and b). Both 
routes are associated with clear evidence of ultrastructural cardiac alteration in mice, with 
swelling of muscle cells, separation of mitochondria and myofibrillar alterations (Terao et al., 
1990; Aune et al., 2002; Tubaro et al., 2003). These alterations showed a rapid onset, 
appearing 40 minutes (Aune et al., 2002) to 24 hours (Tubaro et al., 2003) after acute 
exposure. 
This cardiac tissue damage seems to be only temporary, since it was present 30 days after 
exposure (1 mg YTX/kg/day, for 7 days), while after 90 days a complete recovery occurred 
leaving no differences between control and YTX-treated mice (Tubaro et al., 2008a). 
Notwithstanding the cardiac tissue seems to represent the main toxin target, the effects on the 
functional cardiac properties remain unknown. Isolated cardiac cells are widely used to study 
the functional properties of the cardiac tissue at the single cell level. Hence, this study was 
performed on neonatal rat primary cultures of cardiomyocytes with the aim of investigate the 
effect of YTX on cell vitality and on some fundamental aspects of cellular activity by several 
techniques such as: 
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a) cardiomyocytes contractile activity by patch-clamp recordings, Ca
2+
 imaging, cell beating
 
and 
cyclic AMP levels evaluation; 
b) cell viability by MTT and sulforhodamine B (SRB) tests; 
c) mitochondrial membrane potential by JC-1 and TMRM fluorescent dyes; 
d) apoptotic and necrotic occurrence by nuclei fluorescent staining, caspase assay and PI 
uptake experiments. 
  
 
 
 
MATERIALS & METHODS 
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Isolation of heart cells and preparation of primary cultures 
Neonatal rat cardiomyocytes culture were prepared from one-three day old rat pups according 
to the method of Harary and Farley (1963) with some modifications. Experiments complied 
with the Italian D.L. n. 116 of 27 January 1992 and associates guidelines in the European 
Communities Council Directive of 24 November 1986 (86/609/ECC) concerning animal 
welfare. 
For each culture isolation, twenty to forty Wistar rats obtained from a local conventional 
breeding colony were euthanized by decapitation and allowed to bleed. Hearts were 
aseptically removed by surgical dissection, taking ventricles only, placed in a 100 mm Petri 
dish containing 10 ml of ice-cold Ca
2+
- and Mg
2+
-free Hank‟s balanced salt solution (HBSS) 
and washed thoroughly to remove excess blood. Hearts were then minced into 1 mm
3 
fragments, Hank‟s solution was replaced by 10 ml of 37 °C warm trypsin solution (0.1% w/v) 
and the preparation was stirred (MICROSTIRRER, VELP Scientifica) at 150-200 rpm for 10-
15 minutes at 32-35 °C. Fragments were allowed to settle and supernatant was collected after 
each trypsinization, except for the first one which contains mainly cell debris, red blood cells, 
pericardial and endothelial cells and therefore should be discarded. Supernatant from 
subsequent trypsinizations was collected into 50 ml sterile tubes containing 20 ml of complete 
growth medium (Ham‟s F10 culture medium with 10% horse serum, 10% fetal bovine serum, 
200.000 U/l penicillin, 0.2 g/l streptomycin and 1 mM L-glutamine) to inactivate trypsin 
enzyme. Tubes were centrifuged (ALC Refrigerated Centrifuge PK120R) at 150 x g for 10 
min at 4 °C and resulting pellets were collected all together into one 50 ml tube with 2 ml of 
growth medium and stored on ice. Trypsinizations were repeated until all tissue fragments 
were dissociated (seven to nine trypsinizations). The final cell suspension obtained was 
filtered through 150 µm sterile mesh in order to exclude undissociated cells. Cells were pre-
plated in two 100 mm Petri dishes with complete growth medium (20 ml/dish), and incubated 
at 37 °C in an atmosphere of 95% air and 5% CO2. After one hour, medium was collected to 
harvest unattached cells and pre-plating was repeated a second time as above. Since non- 
muscular cells exhibit a more rapid attachment, this second pre-plating helps to exclude these 
cells and obtain a highly enriched myocyte preparation, as evidenced by cell morphology and 
spontaneous contraction. The myocyte cell suspension was then collected and cells were 
harvested by centrifugation (ALC Centrifuge 4222 MKII) at 102 x g for 5 minutes at room 
temperature (RT) and repeated twice. After pellet re-suspension in complete growth medium 
(10 ml), viable cells were counted in a hemacytometer by trypan blue test (0.4% trypan blue 
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in PBS saline solution) and plated as needed for experiments. Within 24 h of initial culture, 
cardiomyocytes started to exhibit spontaneous rhythmic contractions. Culture medium was 
renewed for the first time 24 h after plating, then every other day as well as the day before 
electrophysiological and Ca
2+
 imaging measurements. All the cultures were employed within 
the fifth day of culture. 
 
Beating frequency experiments 
Cardiomyocytes were plated at a density of 1.2 x 10
6
 cells in 35 mm Petri dishes (2 ml/dish) 
and experiments were performed after 2-3 days of culture. Cultures were exposed to 
increasing YTX concentrations (0.01, 0.03, 0.1, 0.3 and 1 μM) and observed at different time 
points (0.5, 1, 5 and 24 h). Toxin vehicle control dishes were incubated with 1% ethanol. Cell 
beating frequency was evaluated by counting the number of cell contractions per unit time 
under the microscope. Optical fields were randomly chosen and observed for at least 3 
minutes to ascertain the regular occurrence of spontaneous beats. For each experimental point 
10 different fields per 35 mm Petri dish were observed and at least three different dishes were 
analyzed. Each experimental point was carried out with two different cell preparations. 
 
Electrophysiological recordings 
Cardiomyocytes were plated at a density of 1.2 x 10
6
 cells in 35 mm Petri dishes (2 ml/dish) 
and experiments were performed after 2-3 days of culture. Cell membrane potential changes 
were recorded in current-clamp, patch-clamp technique in a normal external solution (NES: 
140 mM NaCl, 2.8 mM KCl, 2 mM CaCl2, 5 mM MgCl2, 10 mM glucose, 10 mM HEPES-
NaOH, pH 7.4) both before and after a 1 h perfusion with 1 µM YTX. Access to the cytosolic 
compartment using the perforated patch clamp method was preferred to conventional whole-
cell recording in order to provide exchange of small ions and to avoid intracellular second 
messenger washout. Membrane potentials were recorded with a pipette solution containing 10 
mM NaCl, 0.005 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 140 mM K-aspartate, 0.1 mM 
EGTA, 2 mM MgATP, 5.6 mM glucose, pH 7.3 and were backfilled with the same solution 
containing amphotericin B (150 µg/ml) made fresh from a stock solution (20 mg/ml in 
dimethyl sulfoxide) kept at 4 °C. All data were acquired at room temperature (22-24 °C) with 
4-6 MΩ patch pipettes using an Axopatch 200B (Axon Instruments, Foster City, CA) 
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amplifier, digitized through a Digidata 1321A interface (Axon Instruments) and stored on a 
PC-compatible hard disk. Currents were acquired at a sampling time of 10 µs and low-pass 
filtered at 2 KHz. For data acquisition and analysis, the pCLAMP software suite (version 8.0, 
Axon Instruments) and Origin 7 (Microcal Software, Northampton, MA) software were 
routinely used. To characterize cardiomyocyte firing properties, single-action potential 
amplitudes, resting potential and discharge frequency were measured. Only stable recordings 
were considered. Action potential amplitude was calculated from the baseline, and firing rate 
was obtained by averaging the instantaneous discharge frequency for at least 10 intervals in 
each recording. 
 
Ca
2+
 imaging experiments 
Cardiomyocytes were plated at a density of 1.2 x 10
6
 cells in 35 mm Petri dishes (2 ml/dish) 
and experiments were performed after 2-3 days of culture. As for membrane potential 
recordings, measurements of the intracellular Ca
2+
 concentration ([Ca
2+
]i) were carried out by 
videoimaging technique before and after cell perfusion for 1 h with 1 µM YTX. Cell loading 
was performed with the fluorescent Ca
2+
 dye fura-2 pentoacetoxymethylester (fura-2 AM) by 
incubation for 30 minutes at RT in NES solution supplemented with 10 mg/ml of bovine 
serum albumin and 5 µM fura-2 AM. During the experiments, cells were maintained in NES 
at a constant temperature of 37 °C. Videomicroscopy setup was composed of an inverted 
microscope (Zeiss, Oberkochen, Germany) equipped with an intensified charge-coupled 
device camera (Hammamatsu Photonics, Hammamatsu, Japan). Cells were alternately excited 
by a modified dual wavelength microfluorimeter (Jasco CAM-230, Tokyo, Japan) at 340 nm 
and 380 nm. Images were acquired at four frames per second. Calculation of 340/380 ratio 
images (pixel-by-pixel) and temporal plot of fluorescence changes were performed off-line. 
Mean fluorescence value was calculated for each cell observed. In temporal plots, fluorescent 
ratio at rest was assumed to be 1, and only fluorescence variations corresponding to a peak 
equal or higher than 1.5 were considered as a cell response. At least five optical fields were 
observed to estimate peak values of [Ca
2+
]i transients and for each experimental condition the 
minimum number of analysed cells was 74. 
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Cyclic AMP quantification 
Cardiomyocytes were seeded in 24-well tissue culture plates at a density of 0.3 x 10
6
 cells/well 
(1 ml/well) 72 h before experiments. Before experiments, cells were pre-incubated with warm 
serum-free medium (1 ml/well) for 10 minutes at 37 °C. Experiments began by replacing 
medium with warm serum free-medium (1 ml/well) containing test compounds and incubating 
cells for 10 minutes, 1, 5 or 24 hours. At the end of incubation time, extracellular medium was 
collected in Eppendorf tubes and stored at -20 C until assayed. Ice-cold 0.1 N HCl was 
simultaneously added (0.25 ml/well) to stop cell reaction and wells were sonicated for 3 minutes 
each. Suspension pH was then neutralized by the addition of ice-cold 0.1 M Tris (0.25 ml/well), 
cells were collected in Eppendorf tubes to be centrifuged at 12,800g for 1 minute at RT 
(Eppendorf Centrifuge 5410) and stored at -20 C until assayed. In each plate, two wells were 
kept for trypsinization (200 μl trypsin solution/well) at the end of experiments to determine 
viable cell number in a hemacytometer by trypan blue test (0.4% trypan blue in PBS saline 
solution). 
Cell cyclic AMP production was determined by displacement of [
3
H] cyclic AMP bound to a 
bovine adrenal extract rich in protein kinase A enzyme as described by Nordstedt and Fredholm 
(1990), with slight modifications (Florio et al., 1999). Different aliquots of each sample were 
added in duplicate in a 96-well MultiScreen-FB microtiter plate (50, 100 or 150 μl/well) together 
with the kinase binding protein solution (50 μl/well), 2 nM [3H] cyclic AMP (37 MBq/ml, 50 
μl/well) and different volumes of buffer (50 mM Tris-HCl, 250 mM NaCl and 10 mM EDTA, 
pH 7.4) up to a final volume of 250 l/well. Plate filter membranes were wetted with ice-cold 50 
mM Tris-HCl buffer (200 l/well) for 5-10 minutes before loading samples. In each plate, a 
standard curve with known increasing quantities of unlabeled cyclic AMP (0.25, 0.5, 1, 2, 4, 8 
and 16 nM final concentration) was run, and maximum (total) bound counts were determined in 
two wells in the absence of non-radiolabeled cAMP. After 150 min at 4 C, the incubation was 
stopped by vacuum filtration using a MultiScreen Vacuum Manifold (Millipore Corporation, 
Bedford, MA) and empty well filters were quickly rinsed once with ice-cold 50 mM Tris-HCl 
buffer (200 l/well) with vacuum still running to remove non-bound cAMP. Plate filters were 
air-dried under a lamp for 5-10 minutes and Optiphase SuperMix liquid scintillation cocktail was 
then added (25 l/well). The microplate was placed in a counting cassette and allowed to sit 
overnight at RT before counting in a MicroBeta Trilux liquid scintillation counter (Wallac, 
Turku, Finland). The amount of cell cyclic AMP was calculated by interpolation of samples 
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counts per minute (cpm) from the linear portion of the standard curve by nonlinear regression. 
Experiments were performed in triplicate and quadruplicate with different cardiomyocyte 
preparations. 
 
MTT viability assay 
The cytotoxic effect of yessotoxin was quantified by the tetrazolium-dye assay introduced by 
Mosmann (1983) based on the ability of yellow soluble 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide (MTT) to form violet formazan crystals when reduced by 
mitochondrial dehydrogenase enzyme. Product quantity absorbance is linearly proportional to 
cell viability. 
Cells were seeded into 96-well plates at a cell density of 0.2 x 10
6
 cells/ml (200 µl/well) in 
complete growth medium. After 24 h, cells were exposed to increasing concentrations of YTX 
(0.0001, 0.001, 0.01, 0.1 and 1 µM) for 24, 48 and 72 h. Toxin vehicle control wells were 
incubated with absolute ethanol for a final concentration of 1%. In a separate set of 
experiments, cells were treated with the same YTX concentrations as above for 1, 5 and 24 h, 
then washed with fresh medium without the toxin to continue cell culture up to 72 h. 
YTX effect on mitochondrial dehydrogenase activity was evaluated also in presence of 
peripheral benzodiazepine receptor ligands PK-11195 and 4-chlorodiazepam. In these 
experiments, cells were exposed for 24 h to YTX, PK-11195 and 4-chlorodiazepam (0.1 µM) 
either alone or associated. When cells were treated with a ligand in presence of YTX, a pre-
treatment with the ligand alone was performed for 1 h. 
MTT solution (5 mg/ml PBS) was added (20 µl/well) 5 hours before the end of incubation 
time. Medium was then removed by vacuum aspiration and cellular formazan crystals were 
solubilized with dimethyl sulfoxide (200 µl/well). Absorbance was measured on an 
Automated Microplate Reader EL 311s (Bio-Tek Instruments, Inc., Winooski, VT) with a 
reference wavelength of 630 nm and a test wavelength of 540 nm. Each set of experiments 
was performed in 12 replicate wells for each toxin concentration and repeated at least three 
times with different cardiomyocyte preparations. 
 
Sulforhodamine B viability assay 
The SRB-based spectrophotometric assay was introduced by Skehan et al. (1990) and its 
excellent linear relationship between staining intensity and cell number as well as cellular 
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protein has been well demonstrated (Haselsberger et al., 1996; Keepers et al., 1991; Voigt, 
2005). Sulforhodamine B (SRB) is a protein dye that under mild acidic conditions 
electrostatically binds to basic amino acid residues of fixed cells and under mild basic 
conditions can be extracted from cells and solubilised for measurement (Voigt, 2005).  
Cells were seeded into 96-well plates at a cell density of 0.2 x 10
6
 cells/ml (200 µl/well) in 
complete growth medium and exposed after 24 h to increasing concentrations of YTX (0.01, 
0.1 and 1 µM) for 24, 48 and 72 h. Toxin vehicle control wells were incubated with absolute 
ethanol for a final concentration of 1%. In a separate set of experiments, cells were treated 
with the same YTX concentration as above for 1, 5 and 24 h, then washed with fresh medium 
without the toxin to continue cell culture up to 72 h. At the end of incubation time, plates 
were centrifuged at 300g for 5 min at RT (Sigma 3K30 Celbio centrifuge), rinsed twice with 
warm calcium- and magnesium-free PBS (100 µl/well) and cells were fixed with ice-cold 
50% (w/v) trichloroacetic acid solution (50 µl/well). After 1 h at 4 °C, wells were rinsed twice 
with bi-distilled water (100 µl/well), and cell proteins were stained with 0.4% sulforhodamine 
B in 1% acetic acid solution (100 µl/well). After 30 min at RT, plates were rinsed three times 
with 1% acetic acid (100 µl/well) to eliminate excess colorant and were allowed to air-dry for 
5 minutes. Protein-bound dye was solubilised by repetitive pipetting of 10 mM 
tris(hydroxymethyl)aminomethane (Tris) solution (200 µl/well) and sample absorbance was 
determined on an Automated Microplate Reader EL 311s (Bio-Tek Instruments, Inc., 
Winooski, VT) with a single wavelength of 570 nm. Each experiment was performed in 8-12 
replicate wells for each toxin concentration and repeated two to three times with different 
cardiomyocytes preparations. 
 
Cell nuclei fluorescent staining 
Cell nuclear DNA was stained to detect toxin-induced morphological alterations by 
fluorescence microscopy. Fluorochrome of choice was 4‟,6-diamidino-2‟-phenylindole 
dihydrochloride (DAPI), which strongly binds to adenine-thymine, adenine-uracil and 
inosine-cytosine base pairs and emits in blue/cyan when excited with ultraviolet light. 
Cells were seeded in 24-well plates aseptically pre-loaded with rounded 13 mm-glass 
coverslips at a seeding density of 0.5 x 10
6
 cells/well in complete growth medium (1 ml/well). 
After 24-48 hours cells were exposed for either 24, 48 and 72 hours to 0.01, 0.1 and 1 µM 
YTX or for 1, 5 and 24 hours to 0.001, 0.01 and 0.1 µM YTX followed thereafter by up to 71 
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additional hours of culture in fresh medium without the toxin. Negative controls and toxin 
vehicle control wells (1% ethanol final concentration) were set up for the same incubation 
times. Positive controls were incubated with 0.5 mM hydrogen peroxide for 1-24 h. Prior to 
cell staining, the wells were washed once with warm 0.1 M PBS (0.5 ml/well) and cells were 
fixed by overlaying with 2% paraformaldehyde in PBS (0.5 ml/well) for 30 minutes at RT. 
The solution was then removed and wells were washed three times with ice-cold 0.1 M PBS 
(0.5 ml/well). Cells were then stored at 4 °C with 0.1 M PBS (0.5 ml/well) until the 
fluorescent staining day. Cell staining began with three rinses for 5 minutes each, with ice-
cold 0.1 M PBS (0.5 ml/well) while rocking plates on a shaker at RT. Non-specific binding 
sites were then saturated by incubation with 0.1 M glycine in PBS (0.5 ml/well) on a plate 
shaker for 5 minutes at RT. Wells were then rinsed three times for 5 minutes each with PBS 
as described above and cell membranes were permeabilized by incubating cells for 5 minutes 
with freshly prepared 0.1% Triton X-100 in 0.1 M PBS (0.5 ml/well). After three additional 5 
minute-washes with PBS as above, cells were stained in the dark for 5 minutes with fresh-
diluted DAPI (1 µg/ml PBS) (100 µl/coverslip). Wells were then washed three times with 
PBS as above and cells were dehydrated with decreasing dilutions of ice-cold ethanol (70, 90 
and 100%) for three minutes each (0.5 ml/well). Glass coverslips were finally harvested and 
mounted onto glass microscope slides (76x26 mm) by pouring a few microliters of 1,4-
diazabicyclo[2.2.2]octane (DABCO)-glycerol directly on the cell side surface. Coverslip 
borders were sealed with the application of clear nail polish and samples were stored at -20 °C 
in the dark. Pictures were acquired at 60x magnification with a NIKON Eclipse E800 
fluorescence microscope equipped with DMX 1200 digital camera.  
 
Glass coverslip preparation for fluorescent microscopy 
Coverslips were first washed with xylene in a closed glass box by repeated shaking for 1 
hour, then rinsed two times with acetone and left in an acetone bath for 2-3 hours, changing 
the solvent each hour. Acetone was then replaced by absolute ethanol and the bath was 
repeated as above. Cleaned coverslips were then stored in 100% ethanol until use. 
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Mitochondrial membrane potential (ΔΨm ) fluorometric measurement with JC-1 dye 
The fluorescent dye of choice was 5,5‟,6,6‟-tetrachloro-1,1‟,3,3‟-tetra-
ethylbenzimidazolocarbocyanine iodide (JC-1), a lipophilic cation that produces two 
fluorescence emission peaks according to its physical form: at low concentration or at low 
ΔΨm value it is principally present as a monomer and emits green fluorescence with an 
emission maximum at 527 nm. Conversely, at high dye concentration or high ΔΨm value a 
multimeric form is predominant that emits orange-red fluorescence with an emission 
maximum at 590 nm (Mathur et al., 2000). Thus, since the amount of cationic dye taken up 
by the mitochondrion depends on its transmembrane potential, at low ΔΨm values the 
fluorescence emission will be mostly green, whereas at high ΔΨm values it will shift to 
orange-red, providing a useful tool to observe the cell mitochondrial polarization state. 
Cardiomyocytes were seeded at a density of 40.000 cells/well into 96-well plates in complete 
growth medium (100 µL/well) and exposed after 24 h to increasing concentrations (0.0001, 
0.001, 0.01, 0.1 and 1 μM) of YTX for 24, 48 and 72 h. In a separate set of experiments, cells 
were treated for 24 and 48 h with 0.1 μM YTX either alone or in the presence of peripheral 
benzodiazepine receptor modulators 4-chlorodiazepam and/or PK-11195 at a concentration of 
0.01 or 0.1 μM. Wells treated with either YTX and these compounds were pre-treated for 1 
hour with inhibitors alone to ensure receptor occupancy before YTX addition. JC-1 kit 
solutions were prepared according to manufacturer protocol: 200 µM dye stock solution (25 
µl) was diluted in a tube with 4 ml of bi-distilled water and gently mixed. The solution sat for 
2 minutes at RT to ensure dye dissolution and 1 ml of 5x staining buffer was then added to the 
tube and mixed by inversion. In a separate tube, 1 mg/ml valinomycin stock solution (1 μl) 
was added to 770 µl of prepared dye solution, and an equal volume of serum-free medium 
was then added to both tubes (4.3 ml and 770 µl), pipetting well to mix. Afterwards, 1 μM 
valinomycin was used as a positive control for its ability to act as a potassium ionophore 
through lipid membranes dissipating membrane potential (Cossarizza, 1997). At the end of 
toxin exposure time, the  medium was removed by vacuum aspiration and replaced with a dye 
solution (0.2 ml/cm
2
 growth surface) to incubate for 20 minutes in a cell incubator at 37 °C. 
The medium was then removed by vacuum aspiration and wells were rinsed two times with 
warm serum-free medium (50 µl/well). Cold medium was then added (50 µl/well) and 
fluorescence was immediately measured. JC-1 aggregates‟ red fluorescence was detected with 
a 535 nm excitation filter and 595 nm emission filter combination whilst the monomers‟ green 
fluorescence was detected with 485 nm excitation filter and 535 nm emission filter 
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combination by an Infinite F200 fluorometer (Tecan Group Ltd, Männedorf, Swizerland). 
Results were expressed as a ratio between red and green fluorescence values and reported as a 
percentage relative to the mean control values. Each YTX concentration was tested in 3 to 12 
replicates and experiments were repeated three to four times with different cardiomyocyte 
preparations. 
 
Caspase activity fluorometric quantification 
A Sensolyte® AFC Caspase Substrate Sampler Kit was used to determine cell caspase 
activity. Seven AFC-based peptide substrates (for caspase-1, -2, -3/7, -6, -8, -9 and -10) were 
chosen. Enzymatic activity profiling is based upon the fluorescent shift of free AFC (7-amino-
4-trifluoromethyl coumarin conjugated at C-terminal) after cleavage from the caspase peptide 
substrate molecule using a fluorescence reader. 
Cardiomyocytes were plated at a density of 40.000 cells/well into 96-well plates in complete 
growth medium (100 µL/well) and, starting 24 h after seeding, were then exposed to 
increasing concentrations of YTX (0.001, 0.01 and 0.1 μM) for 5, 24, 48 and 72 h. Positive 
control wells were exposed to 10 μM camptothecin and 0.1% DMSO was used as vehicle 
control wells. Both no cell- and negative-control wells were set up. Kit solutions were 
prepared according to manufacturer protocol: 1 M DTT was added to kit provided buffer (20 
μl/ml buffer), and used to dilute AFC-based caspase substrate stock solutions to 100 μM as 
the final concentration. At the end of plate incubation time, prepared substrate solutions were 
added to each well (50 μl) and plates incubated for 60 minutes at RT rocking on a plate shaker 
at 100-200 rpm in the dark. An AFC standard curve was prepared by serial dilution of 10 mM 
AFC stock solution to 30, 15, 7.5, 3.75, 1.9, 0.9 and 0.5 μM final concentration in the same 
assay plate (100 μl/well). Fluorescence was measured with 360/35 nm excitation filter and 
460/35 nm emission filter combination in a Microplate Fluorometer (Packard Instrument Co., 
Meriden, CT, USA. Each sample was tested in duplicate and the assay was performed two to 
three times with different cardiomyocyte preparations. 
 
Cell necrosis fluorometric detection with PI dye 
Propidium iodide (PI) is a nuclear staining-fluorescent impermeant dye normally excluded 
from healthy cells, but which penetrates damaged cell membranes of dying or dead cells and 
intercalates into double-stranded nucleic acids. Once bound, its fluorescence is enhanced 20- 
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to 30-fold, with a shift of ~30-40 nm in fluorescence excitation maximum to the red and a 
shift of ~15 nm in fluorescence emission maximum to the blue. 
Cardiomyocytes were plated at a density of 40.000 cells/well into 96-well plates in complete 
growth medium (100 μL/well) and, starting 24 h after seeding, exposed to increasing 
concentrations (0.0001, 0.001, 0.01, 0.1 μM) of YTX for 5, 24, 48 and 72 h. At the end of the 
incubation time, plates were centrifuged (Sigma 3K30 Celbio centrifuge) at 170g for 1 minute 
at RT, medium was removed by vacuum aspiration and replaced with 3 μM propidium iodide 
in PBS (200 μL/well). In positive control wells, cells were lysed by the addition of 10% 
Triton X-100 in PBS (4 μL/well). Plates were incubated for 30 minutes in a cell incubator at 
37 °C. Fluorescence was measured with 530/25 nm excitation filter and 590/20 nm emission 
filter combination in a FluoroCount Microplate Fluorometer (Packard Instrument Co., 
Meriden, CT, USA). 10% Triton X-100 in PBS was then added (4 μL/well) to measure the 
maximum fluorescence value for each well and the plate was incubated for an additional 30 
minutes in a cell incubator at 37 °C. Fluorescence values were measured again with the same 
reading settings. Results were calculated as ratio between fluorescence measured from each 
well relative to its fluorescence maximum, and then expressed as a percentage of negative 
control mean values. Each YTX concentration was tested in 5 replicates and experiments 
were repeated four times with different cardiomyocyte preparations. 
 
Beating HL-1 atrial cardiomyocyte culture 
HL-1 cardiomyocytes were a kind gift of Dr. W. C. Claycomb (Department of Biochemistry 
and Molecular Biology, Louisiana State University Health Science Center, New Orleans, LA) 
and cultured as recommended. Cells were fed every day with Claycomb medium 
supplemented with 10% FBS, 100U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM 
norepinephrine, 2 mM L-glutamine (10 ml/T75-flask). Cultures were passaged twice a week, 
one day after fully confluent, with a dilution factor of three. For each culture flask, 3 new 
flasks were pre-coated by overnight incubation with 0.02% Bacto-gelatin solution with 
fibronectin (0.005 mg/ml) (6 ml/T75-flask) in a cell incubator at 37 °C. To split cultures, each 
flask was gently rinsed with warm 0.05% trypsin/EDTA solution (5 ml/T75-flask), the rinse 
was vacuum aspirated and the solution was added again (3 ml/T75-flask) and left to sit for 2 
minutes at 37 °C. The solution was discarded again and fresh trypsin/EDTA solution was 
added and left for an additional 2-3 minutes. An equal volume of soybean trypsin inhibitor 
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solution (0.25 mg/ml Dulbecco‟s Ca2+- and Mg2+- free PBS) was then added to inactivate the 
enzyme, using a pipet to dislodge cells from the surface. the cell suspension was collected into 
a 15 ml tube and the empty flask was rinsed once with wash medium (Claycomb medium 
containing only 5% FBS and penicillin/streptomycin) (5 ml/T75-flask). This rinse was added 
to the tube and the suspension was centrifuged (Thermo IEC Centra CL2, Thermo Fisher 
Scientific Inc.) at 170g for 5 minutes at RT. Meanwhile, the three newly pre-coated T75-
flasks were empted from the gelatin/fibronectin solution by vacuum aspiration and filled with 
complete Claycomb growth medium (8 ml/T75-flask). Centrifuged supernatant was discarded 
and the cell pellet was gently resuspended in 3 ml of complete growth medium. One ml of cell 
suspension was transferred into each of three coated flasks and cells were grown in a cell 
incubator in a humidified atmosphere of 5 % CO2, 95 % air, at 37 °C. To freeze cultures, cells 
were harvested with the same trypsinization protocol as above, and the pellet resulting from 
centrifugation was re-suspended in freezing medium (95% FBS with 5% DMSO) (1.5 
ml/T75-flask). The contents of each fully confluent T75-flask was collected into one cryovial. 
Cryovials were placed at -80 °C into a Nalgene freezing jar filled with RT isopropanol and 
transferred 6 to 12 hours later into a liquid nitrogen dewar. When cells were needed, one 
cryovial was thawed into one T75-flask. To do this, cells were quickly thawed in a 37 °C 
water bath for about 2 minutes and transferred into a 15 ml tube containing warm wash 
medium (10 ml), then centrifuged (Thermo IEC Centra CL2, Thermo Fisher Scientific Inc.) at 
170g for 5 minutes at RT. The supernatant was discarded and the pellet was re-suspended 
with complete growth medium (5 ml) and placed in a coated T75-flask pre-filled with 10 ml 
of warm growth medium. Medium was replaced soon after cells had attached (4 hours later). 
Cultures employed for experiments were between 63rd and 73rd passage number. 
 
Mitochondrial membrane potential (ΔΨm) fluorometric measurement with TMRM dye 
Tetramethylrhodamine methyl ester (TMRM) is a fluorescent derivative of rhodamine 123 
and accumulates as a lipophilic cation into the mitochondrial matrix in proportion to the 
electrical potential across the inner mitochondrial membrane. Upon accumulation, a red shift 
occurs in both excitation and emission fluorescence spectra and its extent is used to determine 
dye distribution (Scaduto and Grotyohann, 1999). Carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) was used as a positive control for its effect as a 
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proton ionophore causing an altered ion distribution and a depolarized mitochondrial 
membrane.  
Cells were seeded at a density of 50.000 cells/well (100 μl/well). First, cells were loaded with 
50 nM TMRM dye dissolved in medium (35 μl/well), and sat at RT for 30 minutes in the 
dark. Incubation began by exposing cells to 1 µM YTX, 4 or 40 µM FCCP, or 1% methanol 
as a toxin vehicle control, for a final volume of 70 μl/well. Negative controls and no-cell 
wells to quantify background signal were also present. As soon as the incubation started, 
fluorescent measurements were recorded every minute for 60 minutes with an automated 
microplate-based plate reader NOVOstar (BMG Labtechnologies) at an excitation wavelength 
of 544 nm and at an emission wavelength of 570-10 nm. Each treatment was performed in 
duplicate and experiments were repeated two times. 
 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism
®
 software version 4.03 (GraphPad 
Software, Inc., San Diego, CA) and a value of p<0.05 was considered significant. One-way 
ANOVA tests were performed for statistical analyses of one variable, followed by either a 
Dunnett post test, post test for linear trend or Bonferroni post test to compare column pairs. A 
Two-way ANOVA test followed by Bonferroni post test was performed for statistical 
analyses with two variables. Student‟s unpaired t-test was performed by Microsoft Office 
Excel software. 
 
Chemicals 
YTX, a kind gift of Prof. Takeshi Yasumoto (Japan) was isolated from P. reticulatum 
collected in Mutsu Bay (Japan), following the method of Murata et al. (1987). The purity of 
YTX was confirmed by mass spectrometry and by liquid chromatographic methods (Satake et 
al., 1997; Yasumoto and Takizawa, 1997). A stock solution of 100 µM YTX in 95% aqueous 
ethanol was prepared. 
NEN™ Life Science Products: [3H] cyclic AMP (37 MBq/ml); 
Perkin Elmer: Optiphase SuperMix liquid scintillation cocktail; 
Backer: 37% chloridric acid, potassium chloride; 
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Carlo Erba: Sodium chloride; 
Euro€lone: Dulbecco‟s phosphate buffered saline, Penicillin/Streptomycin (10.000 U/ml-
10.000 μg/ml), 200 mM L-Glutamine, Ham‟s F10; amphotericin B; 
Merck: Triton X-100; 
Sigma-Aldhrich: Tetramethylrhodamine methyl ester (TMRM); carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP); methanol; propidium iodide; acetone; 4-
chlorodiazepam; PK-11195; glycine; 1,4-diazabicyclo[2.2.2]octane-glycerol; 4‟,6-diamidino-
2‟-phenylindole dihydrochloride; sulforhodamine B; ethanol; trichloroacetic acid; acetic acid; 
tris(hydroxymethyl)aminomethane; trypan blue; hydrogen peroxide; fura-2 AM; bovine 
serum albumine; glucose; HEPES; forskolin; Claycomb medium, F10 Ham‟s nutrient 
mixture, fetal bovine serum (Lot #8A0177 for HL-1 cardiomyocytes), horse serum, 
norepinephrine [(±)-Arterenol], L-ascorbic acid sodium salt, fibronectin, Trypan blue, 
Sulforodamina B, dimethyl sulfoxide; potassium chloride; calcium chloride; magnesium 
chloride; K-aspartate; Hank‟s balanced salt solution calcium-and magnesium-free (HBSS); 
horse serum; trypsin (T4424); sodium hydroxide; MagnesiumATP; Ethylene glycol-bis(2-
aminoethylether)-N,N,N’,N’-tetraacetic acid; mitochondria staining kit (CS0390); 
AnaSpec Corporate: SensoLyte AFC caspase sampler kit, fluorimetric (71117); 
Millipore Corporation: 96-well MultiScreen-FB microtiter plate; 
Life Technologies: Penicillin-streptomycin (10
4
 U/ml-10
4
 μg/ml), 200 mM L-glutamine, 
trypsine/EDTA (25300-054), soybean trypsin inhibitor, cell culture-grade distilled water; 
Invitrogen: Dulbecco‟s Ca2+- and Mg2+- free PBS; 
Fisher Scientific: Bacto-gelatin. 
  
 
 
 
RESULTS 
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Beating frequency observation after continuous exposure to YTX 
Yessotoxin-exposed cardiomyocytes showed a concentration- and time-dependent reduction 
of beating frequency. Cells were observed at different time points (0.5, 1, 5, 24 h) after 
exposure to increasing YTX concentrations (0.01 up to 1 μM). Results are shown in figure 2 
as YTX concentration on the X axis and as corresponding beating frequency value expressed 
as a percentage relative to control values on the Y axis. After 0.5 h exposure no reduced 
beating activity was observed (data not shown). After 1 h, its decrease was observed in a 
time- and concentration-manner at all toxin concentrations tested, becoming significant at 0.3 
µM YTX. After 5 hours the pattern was similar, while at 24 hours beating frequency 
reduction was significant starting from 0.1 µM YTX.  
 
 
Figure 2: YTX effect on cardiomyocyte beating frequency 
Data are reported as mean ±SEM (n= 40-50 fields) of samples 
assayed in triplicate. Experiments were repeated two times with 
two different cell preparations. 
* p<0.05 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
 
Among cardiomyocyte cells, 86.4 ±6.8% were regularly beating (n=60 fields). A >50% 
reduction in number of beating cells was observed after a 24 hour exposure to 1 µM YTX.  
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Results are shown in figure 3 as a percentage of beating cells with respect to total cell 
number.  
               
□ before 1 μM YTX exposure 
■ after 1 μM YTX exposure 
 
Figure 3: YTX effect on number of beating cardiomyocytes  
Data are reported as mean ±SEM (n=30 fields). 
* p<0.05 vs control (Student t-test). 
 
 
Membrane electrical activity and Ca
2+
 release from intracellular stores in presence of 
YTX 
Cardiomyocyte firing frequency was affected by YTX treatment. Patch-clamp and calcium 
imaging technique recordings were performed on cells before and after 1 h perfusion with 1 
µM YTX. Changes in both membrane potential and calcium transients were measured in the 
same cell. Results are shown in figure 4 as membrane potential (mV) in the upper panel and 
the corresponding [Ca
2+
]i pick in the lower panel. The pattern for control cells is shown on the 
left half of the figure and for YTX-exposed cells on the right half. A decrease in the firing 
frequency of about 50% with respect to untreated cells was observed without any 
corresponding change in either resting or action membrane potential amplitude (from 50.3 
±0.1 mV to 51.6 ±0.1 mV, n=30 cells). Similarly, both basal and peak [Ca
2+
]i transient values 
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were not affected by toxin exposure (from 1.9 ±0.1 mV to 1.8 ±0.2 mV; n=80 cells, 15 fields). 
As in control conditions, in the presence of YTX each action potential always remained 
associated to a [Ca
2+
]i transient. 
 
 
 
Figure 4: YTX effect on cardiac cells electromechanical 
coupling 
Results are reported as changes in membrane potential voltage 
(n=30 cells) and corresponding [Ca
2+
]i transient (n=80 cells). 
 
 
Intracellular cAMP accumulation in presence of YTX  
Cardiomyocyte intracellular cyclic AMP levels were significantly affected by YTX. Adenylyl 
cyclase enzyme activity was directly stimulated with 10 μM forskolin simultaneously with 
exposure to increasing toxin concentrations (0.0001, 0.001, 0.01 and 1 μM). Experiments 
were performed at 10 minutes, a time point determined by preliminary time-course 
experiments (data not shown). Results are shown in figure 5 as intracellular cyclic AMP pmol 
produced per million of cells on the Y axis. A significant reduction (p<0.01) of cAMP levels 
was observed only in 1 µM YTX exposed cells (-33 ±11% vs control cells).  
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Figure 5: YTX effect on intracellular cAMP accumulation in 
presence of forskolin (FK) 
Data are reported as mean ±SEM of samples assayed in 
triplicate or quadruplicate. Experiments were repeated two times 
with two different cell preparations. 
* p<0.01 vs control (One-way ANOVA with Dunnet post test). 
 
 
On the contrary, when adenylyl cyclase activity was not stimulated, YTX did not alter cyclic 
nucleotide levels. Cells were exposed for 10 minutes or 1, 5, and 24 hours to 1 µM YTX and 
compared to control cells. Results are shown in figure 6 as pmol of intracellular cAMP 
produced per million of cells on Y axis and each group of bars represents a different time 
point measurement of both control and YTX-exposed cells. YTX did not caused appreciable 
variations of cAMP content with respect to controls at any time point. A progressive increase 
in cAMP content was found in both treated and untreated cells, but no significant difference 
between the two groups was found. 
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Figure 6: YTX effect on intracellular cAMP accumulation in 
basal condition 
Data are reported as mean ±SEM of samples assayed in 
triplicate or quadruplicate with two different cell preparations. 
No significant difference between control and treated cells was 
calculated (Two-way ANOVA with Bonferroni post test). 
 
 
Cell viability assessment after continuous YTX exposure  
Cardiomyocytes exposed to increasing concentrations of YTX showed a reduced viability in a 
concentration- and time-dependent way. Cells were exposed to increasing concentrations of 
YTX (0.0001, 0.001, 0.01, 0.1 and 1 μM) for 24, 48 and 72 hours. Results are shown in figure 
7 as a percent viability of treated cells with respect to control. After 48 hours of incubation, a 
significant (p<0.001) decrease of mitochondrial activity was observed starting from 0.01 µM 
YTX and after 72 h a similar pattern was observed. Two-way ANOVA evidenced a 
significant (p<0.001) influence of incubation time, toxin concentration and their interaction 
(accounting for 49.4%, 19.3% and 22.3% of total variance, respectively). On the contrary, 
cells treated for 24 h resulted in a significant increase in mitochondrial activity at all 
concentrations of YTX tested. 
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Figure 7: YTX effect on cardiomyocyte viability by MTT 
assay 
Data are reported as mean ±SEM (n=12) of viability percentage 
with respect to control cells. Experiments were repeated three 
times with different cell preparations. 
* p<0.001 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
Under the same experimental conditions, results obtained by MTT assay were confirmed by 
the SRB assay that determines cell number by protein content. After 48 and 72 h, a time- and 
concentration-dependent viability reduction occurred at all toxin incubation time. Cells were 
exposed to 0.01, 0.1 and 1 μM YTX for 24, 48 and 72 hours and results are shown in figure 8 
as cell number percentage with respect to control. After 24 hours, a significant decrease in cell 
number was observed starting from 0.1 µM YTX (p<0.01), and after 48 h of incubation the 
effective concentration lowered to 0.01 µM YTX (p<0.001). Similar results were obtained 
after 72 hours exposure.  
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Figure 8: YTX effect on cardiomyocyte cell number by SRB 
assay 
Data are reported as mean ±SD (n=8-12) of cell number 
percentage with respect to control. Experiments were repeated 
three times with different cell preparations. 
+ p<0.01 vs control (Two-way ANOVA with Bonferroni post 
test); 
* p<0.001 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
 
Cell viability assessment after a prolonged washout in YTX-free medium 
 
In a second set of experiments, cells were exposed to increasing YTX concentrations up to 24 
hours. Medium was then replaced by YTX-free medium and cell cultures were maintained up 
to the fifth day of culture. These experiments were performed in order to evaluate the 
potential recovery of toxin-exposed cells. Results obtained showed a time-dependent reduced 
viability even after a short time exposure such as 1 hour with no recovery of viability after up 
to 71 h. Cells were exposed to increasing concentrations of YTX (0.0001, 0.001, 0.01, 0.1 and 
1 μM) for 1, 5 and 24 hours and maintained thereafter in YTX-free medium up to 71, 67 and 
48 hours, respectively. Results are shown in figure 9 as percent viability of treated cells with 
respect to control. After 1 h exposure a significant (p<0.001) reduction in viability was found 
starting from 0.1 µM YTX. After 24 hours of treatment, 0.01 µM YTX was the lowest 
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effective concentration. With analysis by Two-way ANOVA, a significant (p<0.001) effect of 
YTX concentration, length of exposure and their interaction was observed, accounting for 
87.0%, 2.9% and 4.7% of total variance, respectively. 
 
 
Figure 9: YTX effect on cardiomyocyte viability by MTT 
assay 
Data are reported as mean ±SEM (n=12) of viability percentage 
with respect to control cells. Experiments were repeated two 
times with different cell preparations. 
* p<0.001 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
 
Comparable results were obtained performing the SRB test under similar experimental 
conditions. Cells were exposed to 0.01, 0.1 and 1 μM YTX for 1, 5 and 24 hours and 
maintained thereafter in YTX-free medium up to the fifth day of culture. Results are shown in 
figure 10 as cell number percentage with respect to control. One hour exposure to 0.1 µM 
YTX was sufficient to dramatically reduce cell number (p<0.001), and a similar pattern was 
observed after 5 hours. 24 hours of exposure to the toxin followed by 48 hours in toxin-free 
medium resulted in a decrease of cell number at all concentrations tested. Under this 
condition, the percentage of living cells was lower than after 24 h of continuous contact to the 
toxin (-80.45 ±8.13% vs -24.85 ±5.64%, respectively, after 1 µM YTX treatment). 
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Figure 10: YTX effect on cardiomyocyte cell number by 
SRB assay 
Data are reported as mean ±SD (n=12) of cell number 
percentage with respect to control. Experiments were repeated 
two times with different cell preparations. 
* p<0.001 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
 
Nuclear morphology after continuous YTX exposure 
Increasing concentrations of YTX induced the appearance of nuclear apoptotic bodies in 
cardiomyocytes. In DAPI-stained cells, nuclei are considered to have a normal phenotype 
when glowing bright and homogenously. Apoptotic alterations present as either condensed 
chromatin gathering at the periphery of the nuclear membrane or a total fragmented 
morphology of nuclear bodies. 
Cells were exposed to 0.001, 0.01 and 0.1 μM YTX for 1, 5 and 24 h and cultures were fixed 
at the end of the treatment. Positive control wells were exposed to 0.5 mM hydrogen peroxide 
for 1, 5 and 24 h. Pictures were acquired with 60x magnification. YTX had a time-dependent 
effect (see figure 11). A percentage quantification was not possible because of the cluster 
nature of the culture. 
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control cells 0.5 mM hydrogen peroxide 
 (1 h) (24 h) 
 
0.001 μM YTX 0.01 μM YTX 0.1 μM YTX 
 
 
 
 
 
Figure 11: Cardiomyocytes nuclear morphology after continuous YTX exposure for 1 h 
(first row), 5 h (second row) or 24 h (third row) 
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Nuclear morphology after prolonged washout in YTX-free medium 
In a second set of experiments, cells were exposed to 0.01, 0.1 and 1 μM YTX for 1, 5 and 24 
h. Cultures were then maintained up to the fifth day of culture in YTX-free medium and then 
fixed. Pictures were acquired with 60x magnification. A percentage quantification was not 
possible because of the cluster nature-behaviour of the culture. Both concentration- and time-
dependent effects of the toxin are observable in figure 12, together with a significant loss in 
cell number. 
 
0.01 μM YTX 0.1 μM YTX 1 μM YTX 
 
 
 
 
Figure 12: Cardiomyocytes nuclear morphology after 1 h (first row), 5 h (second row) or 
24 h (third row) exposure to YTX, followed by 71, 67 and 48 h, respectively, in YTX-free 
medium 
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Caspase activity after continuous exposure to YTX 
No caspase activation was found in YTX-treated cardiomyocytes. Cardiomyocytes were 
exposed to increasing concentrations of YTX (0.001, 0.01 and 0.1 μM) for 5, 24, 48 and 72 h. 
Positive control wells were exposed to the apoptosis inducer 10 µM camptothecin for 24 
hours. Results are reported only for the highest YTX concentration employed (0.1 μM) after 
72 h. In table 1 are grouped data for initiators of the apoptosis pathway and in table 2 are 
grouped data for executors of the apoptosis pathway as well as for caspase 1, an isoform 
involved in cytokine activation. Data are reported as fluorescence units (mean ±SD) of free 
AFC fluorochrome released by caspase hydrolysis of AFC-peptide complexes. Results after 5, 
24, and 48 h were equally ineffective at all YTX concentrations tested. 
 
Table 1: YTX effect on apoptosis initiator caspases 2, 8, 10 and 9 activity 
 
caspase 2 caspase 8 caspase 10 caspase 9 
(fluorescence units) 
control 3.462 ±1 3.235 ±59 4.827 ±33 2.279 ±16 
10 μM camptothecin (24 h) 19.731 ±56 19.763 ±380 21.080 ±162 18.553 ±82 
0.1 μM YTX (72 h) 3.374 ±0 3.176 ±30 4.362 ±306 2.188 ±6 
 
 
 
Table 2: YTX effect on caspase 1 and on apoptosis executor caspases 3/7 and 6 activity 
 
caspase 1 caspase 3/7 caspase 6 
(fluorescence units) 
control 2.448 ±12 5.525 ±38 3.790 ±16 
10 μM camptothecin (24 h) 18.613 ±76 21.826 ±128 19.930 ±354 
0.1 μM YTX (72 h) 2.334 ±1 5.221 ±26 3.647 ±32 
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Cell necrosis after continuous exposure to YTX 
Propidium iodide (PI) experiments were performed in order to investigate YTX effect on cell 
viability. YTX induced concentration- and time-dependent cell death. Cardiomyocytes were 
exposed to 0.0001, 0.001, 0.01 and 0.1 μM YTX for 5, 24, 48 and 72 h. Results are reported 
in figure 13 and were calculated for each well as a ratio between YTX-induced PI 
fluorescence above PI fluorescence maximum, and then expressed as a percentage of negative 
control values. After a 5 h exposure no significant increase was detected in any of the YTX 
concentrations. A significant increase of PI uptake was detected after 24 h exposure starting 
from 0.01 µM YTX (p<0.01). After 48 hours exposure, the lowest effective concentration was 
0.001 µM YTX (p<0.01), increasing the uptake value from 20 ±6% to 64 ±3% at 72 hours 
(p<0.001). 48 hour and 72 hour treatments resulted in a similar pattern. Two-way ANOVA 
revealed a significant (p<0.001) effect of YTX concentration, length of exposure and their 
interaction, accounting for approximately 36.5%, 29.2% and 25.6% of total variance, 
respectively. One-way ANOVA with post test for linear trend performed for each exposure 
time revealed a significant linear trend at all times tested (p<0.0001). 0.01 µM YTX vs 0.1 
µM YTX values were not significantly different at all times tested (One-way ANOVA with 
Bonferroni post test for column pairs). 
 
Figure 13: YTX effect on cardiomyocyte viability by PI uptake 
Data are reported as mean ±SEM (n=16-24) Experiments were 
repeated four times with three different cardiomyocyte preparations. 
+ p<0.01 vs control (Two-way ANOVA with Bonferroni post test); 
* p<0.001 vs control (Two-way ANOVA with Bonferroni post test). 
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Short-term time course for YTX effect on mitochondrial membrane potential 
In HL-1 cardiomyocytes exposed to 1 µM YTX up to 60 minutes, no mitochondrial 
membrane potential (ΔΨm) depolarization occurred. Cells were exposed to 1 µM YTX or to 
the depolarizing agent carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (4 or 
40 µM) as a positive control. TMRM dye fluorescence readings were acquired every minute 
for 1 h, beginning as soon as incubation started (figure 14). No significant difference was 
foundbetween control and YTX-treated cells by Two-way ANOVA with Bonferroni post test 
analysis. 
 
 
Figure 14: YTX effect on ΔΨm by TMRM dye 
Data are reported as mean of fluorescence units of one 
representative experiment. Experiments were performed in 
duplicate and repeated two times.  
 
 
Time course for YTX effect on mitochondrial membrane potential 
In neonatal rat cardiomyocytes, altered mitochondrial membrane potential (ΔΨm) was found 
by JC-1 dye. Cells were exposed to 0.0001, 0.001, 0.01, 0.1 and 1 µM YTX for 24, 48 and 72 
hours. The depolarizing agent valinomycin 1 µM was used as a positive control. Data are 
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reported in figure 15 as a percentage relative to control of the ratio between fluorescence units 
emitted in red and above green wavelengths. 
Data analysis by Two-way ANOVA found a significant (p<0.0001) effect of concentration, 
exposure time and their interaction, accounting for approximately 13.5%, 31.2% and 25.8% 
on total variance, respectively. Bonferroni post test calculated a significant effect of toxin 
treatment on ΔΨm at 24 h starting from a concentration equal to 0.01 μM (p<0.001). After 48 
h, all YTX concentrations showed a modified ΔΨm, with a significance equal to p<0.05 for 
0.0001 μM and 0.001 μM YTX, and p<0.001 for 0.01, 0.1 and 1 μM YTX. At 72 h a similar 
pattern was observed. 
 
 
 
Figure 15: YTX effect on ΔΨm by JC-1 dye 
Data are reported as mean ±SEM. Experiments were performed 
in 5-12 replicates for each treatment and repeated two to six 
times with different cardiomyocyte preparations. 
x p<0.05 vs control (Two-way ANOVA with Bonferroni post 
test);  
** p<0.001 vs control (Two-way ANOVA with Bonferroni post 
test). 
 
 
 
___  Res u lts  
45 
 
Effect of peripheral benzodiazepine receptor ligands on YTX mitochondrial effect 
By MTT assay, the effect of YTX on mitochondrial dehydrogenase activity was not affected 
by the modulation of peripheral benzodiazepine receptor activity. Neonatal rat 
cardiomyocytes were exposed for 24 hours to 0.1 μM YTX either alone or in the presence of 
0.1 μM peripheral benzodiazepine receptor modulators 4-chloro-diazepam and/or PK-11195. 
Results are reported in table 3 as mean ±SD of percentage relative to control values for 
mitochondrial dehydrogenase activity. Data analysis by One-way ANOVA with the Tukey-
Kramer post test showed no significant effect. 
 
Table 3 
PBdzR modulators effect on 24 hYTX-exposed cells by MTT assay 
 
 
compound 
viability 
(% of control) 
 
YTX 0.1 μM 
 
 
29.1 ±5.6 
 
PK-11195 0.1 μM 
PK+YTX 
 
11.3 ±6.3 
36.8 ±8.7 
 
4-chloro-diazepam 0.1 μM  
4-chloro-diazepam+YTX  
 
7.1 ±3.7 
33.5 ±5.6 
 
PK-11195+4-chloro-diazepam 
PK-11195+4-chloro-diazepam+YTX 
7.3 ±9.4 
31.6 ±5.4 
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In a separate set of experiments, the effect of YTX on the mitochondrial membrane potential 
(ΔΨm) in the presence of peripheral benzodiazepine receptor ligands was tested by JC-1 dye. 
Neonatal rat cardiomyocytes were exposed for 24 or 48 hours to 0.1 μM YTX, either alone or 
in the presence of one or both peripheral benzodiazepine receptor modulators 4-chloro-
diazepam and/or PK-11195 (0.1 or 0.01 μM). Results after both 24 and 48 h incubation are 
shown in table 4 as mean ±SEM of the percent relative to control of the ratio between JC dye 
fluorescence units emitted in red and above green wavelengths. Data analysis with One-way 
ANOVA with Tukey-Kramer post test did not found any significant difference between YTX 
alone and YTX with one or both receptor ligands. 
 
Table 4 
PBdzR modulators effect on 24 and 48 h YTX-exposed cells by JC-1 dye 
 
 
 
compound 
595/535 nm (% of control) 
24 h 48 h 
valinomycin 1 μM -35.5 ±2.5 -32.4 ±1.9 
YTX 0.1 μM 24.3 ±2.2 -43.6 ±3.0 
PK-11195 0.1 μM 
PK+YTX 
-16.7 ±2.5 
13.0 ±4.6 
-15.1 ±5.1 
-48.5 ±4.1 
4-chloro-diazepam 0.1 μM 
4-chloro-diazepam+YTX 
-14.4 ±2.8 
18.1 ±2.4 
-22.3 ±4.2 
-47.2 ±4.0 
PK-11195+4-chloro-diazepam 
PK-11195+4-chloro-diazepam+YTX 
-11.1 ±1.6 
10.2 ±1.4 
-8.7 ±2.3 
-50.0 ±5.2 
  
 
 
 
 
DISCUSSION 
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Cardiomyocytes exposed to YTX showed a concentration- and time-dependent reduction of 
beating frequency starting from 1 h exposure to 0.3 µM YTX. No reduced beating activity 
was observed after 0.5 h exposure. Cardiac contraction and relaxation activity rely on the 
processes of excitation-contraction coupling. These processes start with the initial cell 
membrane depolarization through voltage-gated sodium channels activation, the consequent 
voltage-dependent opening of L-type voltage-gated calcium channels, the Ca
2+
-induced Ca
2+
-
release through ryanodine receptors located on sarcoplasmic reticulum, and finally the 
binding of cytosolic calcium to the myofilaments and cell contraction. A major deficit in 
failing myocytes is the reduced Ca
2+
 content of the sarcoplasmic reticulum (SR), that together 
with related altered mechanisms, lead to smaller and dyssynchronous SR calcium release 
(Maack and O‟Rourke, 2007). In cardiomyocytes exposed to YTX, a 50% reduction of fire 
frequency occurred after 1 h perfusion (1 µM YTX), but no change was found in both resting 
and action membrane potential amplitude. Moreover, both [Ca
2+
]i basal and peak values were 
not affected by toxin exposure: as in control conditions, YTX-exposed cells showed action 
potentials always associated to a [Ca
2+
]i transient. These results exclude a YTX-induced 
impairment of excitation-contraction coupling, calcium release or action potential amplitude. 
Literature data from previous in vitro studies reported already only a modest effect of YTX on 
calcium movements in mammalian cells, also with high concentration (1 µM YTX) (de la 
Rosa et al., 2001a; 2001b). Moreover, the presence of calcium channel blockers did not 
prevented rat cerebellar neurons cell death (Pérez-Gómez et al., 2006).  
Another second messenger regulating heart rate is cyclic AMP (cAMP), that through cAMP-
dependent kinase A (PKA) could mediate several fundamental processes in the heart, 
including cardiac contractility and action potential duration (DiFrancesco, 2006). YTX has 
been previously found to slightly affect intracellular cAMP levels on human lymphocytes 
(Alfonso et al., 2003), an effect related to toxin ability to bind to several phosphodiesterases 
(Alfonso et al., 2005; Pazos et al., 2006; Mouri et al., 2009). In the present study, 
cardiomyocytes intracellular cyclic AMP levels were significantly reduced (p<0.01) only at 
the highest concentration employed (1 µM YTX) and with a modest effect (-33 ±11% vs 
control cells). Moreover, this effect could be observed only in presence of a direct activator of 
adenylyl cyclase: in non-stimulated condition, YTX did not altered cyclic nucleotide levels, 
even after longer exposure time such as 24 hours. These results lead to exclude a highly 
affected cAMP pathway at the bases of cardiomyocytes reduced firing activity. 
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Since in beating cells number observations a ~50% reduction of beating cardiomyocytes was 
found after a 24 hours exposure to 1 µM YTX, the possible correlation to a reduced cell 
viability was investigated. Cardiomyocytes were exposed to increasing concentrations of 
YTX for 24, 48 and 72 hours and MTT and SRB assays were performed. A concentration- 
and time-dependent reduction of viability was found after 48 h of incubation, with a 
significant (p<0.001) decrease of mitochondrial activity observed starting from 0.01 µM 
YTX. After 72 h a similar pattern occurred.  
Interestingly, 24 h exposure caused a significant (p<0.001) increase in mitochondrial 
dehydrogenase activity at all YTX concentrations tested (0.0001-1 μM). This effect could be 
due to an increased cell number, but adhered cells quantification by SRB assay excluded this 
possibility, founding a significant decrease in cell number starting from 0.1 µM YTX 
(p<0.01). An influx of Ca
2+
 into the cytosol and its consequent sequestering into the 
mitochondria has been reported to activate respiratory dehydrogenases and oxidative 
phosphorylation (Lemasters et al., 2009). Previous studies reported a slight YTX-induced 
increase of intracellular Ca
2+
 content in human lymphocytes (de la Rosa et al., 2001a and 
2001b), rat cerebellar neurons (Pérez-Gómez et al., 2006) and immunocytes from the mussel 
Mytilus galloprovincialis (Malagoli et al., 2006a). On the contrary, similarly to the findings of 
the present study, no altered calcium homeostasis in mouse skeletal muscle seem to occur 
(Tubaro et al., 2008b). In cardiac myocytes, both cytosolic and mitochondrial Ca
2+
 levels 
increase transiently during the contractile cycle, as part of excitation-contraction coupling, 
and possibly stimulate mitochondrial ATP production on a beat to beat basis (Lemasters et al., 
2009). Because cardiac myocytes, as well as skeletal muscle, experience constant fluctuations 
of free Ca
2+
, ion level control could be more efficient than other cell types, and a small YTX-
induced calcium increase could not affect calcium transients or excitation-contraction 
coupling. 
Mitochondria occupy a central position in cell survival/cell death decision. Mitochondrial 
membrane potential is a key factor for a functional organelle and whilst a transient loss of 
mitochondrial membrane potential is physiological, a long lasting dissipation is associated 
with cell death (Korichneva et al., 2003; Iijima et al., 2003), although available literature data 
still didn‟t identified an exact cause-consequence sequence and several different pathways are 
possible. In the heart, mitochondria occupy about 30% of myocyte cell volume: their high 
number is related to the high metabolic demand of heart tissue and their role as buffer of 
cytosolic calcium levels (Baskin, 1991). YTX effects on both mitochondrial activity and 
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apoptosis are perhaps the aspects that have been mostly investigated in vitro until now, 
showing different sensitivity among cell lines and cell line-specificity in biochemical 
responses. A reduction of mitochondrial membrane potential in the BE(2)-M17 
neuroblastoma cell line has been found at high concentration (1 μM YTX) starting after 12 
hours incubation (Leira et al., 2002) and similar results were found in rat L6 and mouse 
BC3H1 skeletal muscle myoblasts after 24 or 48 hours exposure (100 nM YTX), respectively 
(Suárez Korsnes et al., 2006b). In cardiomyocytes culture, a significantly reduced 
mitochondrial membrane (mitochondrial depolarization) occurred after 48-72 hours exposure 
to 0.01-1 μM YTX (p<0.001). On the contrary, a significant (p<0.001) increase in 
mitochondrial membrane polarization (hyperpolarization) occurred at the same toxin 
concentrations after 24 hour incubation. This could be in agreement with MTT results 
obtained after 24 h exposure. In neurons, the hyperpolarization produced by specific 
inhibition of the mitochondrial Na
+
/Ca
2+
 exchanger has been correlated to the increase in 
matrix Ca
2+
 and the consequent Ca
2+
-dependent increased metabolic activity. An important 
role for matrix Ca
2+
 in matching ATP production with cellular activity has been proposed, 
since two key enzymes of the tricarboxylic acid cycle as well as the overall activity of the 
electron transport chain are upregulated by matrix Ca
2+
 levels achieved in stimulated cardiac 
myocytes (White and Reynolds, 1996). However, contrasting opinions are described in 
literature (see below). 
The mitochondrial permeability transition is the consequence of causes such as calcium 
overload, reactive chemicals and oxidative stress. This process activates a large conductance 
permeability transition pore that makes the mitochondrial inner membrane permeable to all 
solutes of molecular weight up to about 1500 Da, with consequent mitochondrial 
depolarization, uncoupling of oxidative phosphorylation and mitochondrial swelling driven by 
colloid osmotic forces that ends in the rupture of mitochondrial outer membrane. Pore 
composition remains controversial: a multicomponent protein complex assembles at contact 
sites of inner and outer mitochondrial membranes and its constituents comprehend the 
voltage-dependent anion channel, adenine nucleotide translocase, hexokinase, creatine kinase, 
cyclophilin D and peripheral benzodiazepine receptor (Kroemer et al., 2007; Lemasters et al., 
2009). This latter component is a receptor for benzodiazepines abundantly expressed in 
mitochondrial membranes of most peripheral tissues. Its pharmacology is distinct from the 
central receptor subtype and it is selectively inhibited by the benzodiazepine Ro5-4864 (4‟-
chlorodiazepam) as well as the nonbenzodiazepine isoquinoline carboxamide derivative PK-
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11195. These ligands block the mitochondrial inner membrane anion channel stabilizing the 
inner membrane potential, and can block or prevent if beforehand mitochondrial inner 
membrane potential depolarizations triggered by metabolic stress. Moreover, a peculiar heart 
protective role has been shown for 4‟-chlorodiazepam (Akar et al., 2005). 
In the present study, YTX-altered mitochondrial potential in neonatal rat cardiomyocytes 
wasn‟t affected by either PK-11195 and/or 4-chlorodiazepam after 24-48 h exposure. When 
cells were incubated with receptor ligand only, the membrane depolarization occurred, for an 
averaged value of ~16% for PK-11195, ~18% for R5-4864 and 10% for their association. This 
could be related to the depressing effects on cardiac activity of these compounds, such as the 
significant reduction in indices of contractility, aortic flow, stroke work and total pressure-
volume area in isolated working rat heart model (Edoute et al., 1993), negative inotropic and 
chronotropic effects (Gesi et al., 1999). 
Results obtained at 24 hours were confirmed by MTT assay, with no altered YTX-induced 
mitochondrial dehydrogenase activity in presence of peripheral benzodiazepine receptor 
ligands Ro5-4864 and/or PK-11195. 
Mitochondrial permeability transition occurs in several forms of cell death, included necrosis, 
apoptosis and autophagy (Lemasters et al., 1998). Several authors already reported a YTX-
induced apoptotic effect, DNA fragmentation and caspase 3-7-9 activation with great 
difference in sensitivity among cell lines (Leira et al., 2002; Malaguti et al., 2002; Pérez-
Gómez et al., 2006; Suárez Korsnes et al., 2006a). On the contrary, YTX failed to induce 
DNA fragmentation in rat and mouse skeletal muscle myoblast (Suárez Korsnes et al., 
2006a); a pro-apoptotic effect in both IPLB-LdFB insect fat body and NIH3T3 mouse 
fibroblast cells (Malagoli et al., 2006b), activation of caspase-3 and -7 or fragmentation of 
poly(ADP)ribose polymerase in both Caco-2 and MCF-7 cells have also been reported 
(Callegari and Rossini, 2008).  
To test whether cardiomyocytes depolarization was concomitant to an apoptotic event, treated 
cells were stained with nuclear fluorochrome DAPI. A YTX-induced appearance of nuclear 
apoptotic bodies was observable after both continuous exposure for 1, 5 and 24 h, with a time-
dependent effect, and after 1, 5 and 24 h treatment observing cells after up to 71 hours in 
culture without the toxin, with a concentration- and time-dependent effect. 
To confirm the apoptotic effect of YTX, caspase activity was measured after 5, 24, 48 and 72 
h exposure to YTX (0.001 up to 0.1 μM). In contrast to expectations, results obtained showed 
no caspase activation for initiator caspases 2, 8, 10 and 9; as well as for executor caspases 3, 6 
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and 7 and caspase 1, involved in cytokine activation. These results are in contrast to some of 
previous studies performed on different cell lines, whilst are in agreement with no apoptotic 
DNA fragmentation occurrence found in mice heart tissue sections from in vivo studies by 
TUNEL staining (Tubaro et al., 2003; 2004). 
Moreover, these findings can be related to mitochondrial membrane potential observations. 
Since proton re-entry during ATP production in complex V normalizes mitochondrial 
membrane potential and prevents hyperpolarization, this alteration could mean a disturbance 
of the electron transport system (Iijima et al., 2003). ATP is essential for cell apoptosis: the 
so-called apoptosome complex formed after cytochrome c release from mitochondria finally 
activates procaspase 9 to caspase 9 in an ATP or dATP dependent fashion. When ATP is 
depleted, apoptosis is blocked (Kim et al., 2003). It would be useful to monitor 
cardiomyocytes ATP levels in the first 48 hours of exposure to YTX for a better 
understanding. 
A morphological damage due to insufficient amount of ATP has been described when the 
coronary flow is re-established after a prolonged ischemic episode: the partial recovery of 
mitochondrial function generates an amount of ATP sufficient for contraction but not for 
relaxation, resulting in hyper-contracture and sarcolemma rupture. This effect can be 
prevented by respiratory chain inhibitors or mitochondrial uncouplers as well as by inhibition 
of myosin ATPase (Bernardi et al., 2006). This could explain the ultrastructural alterations 
such as separation of bundles of myofibrils, sarcoplasmic reticulum and T-systems observed 
in tissue preparations from mice treated with YTX (J.S. Ramsdell, personal communication) 
in several in vivo studies (Terao et al., 1990; Aune et al., 2002; Tubaro et al., 2003; 2004; 
2008a). 
A separate set of cytotoxicity experiments was performed by both MTT and SRB assays to 
evaluate both the entity and the reversibility of cytotoxic damage in YTX-exposed 
cardiomyocytes. Results obtained showed a time-dependent reduced viability even after a 
short time of exposure such as 1 hour (0.1 µM YTX) with no recovery of viability after up to 
71 h in YTX-free culture. After 24 hours of exposure, 0.01 µM YTX was the lowest effective 
concentration. These results suggest a cell damage consequent to toxin exposure that once 
triggered leads irreversible to cell death. 
Since no caspase activation occurred, the apoptosis pathway seems to be improbably involved 
in YTX cytotocicity on cardiomyocytes, and two other cell death mechanisms could be 
considered: necrosis and autophagy. Necrosis causes disruption of the plasma membrane 
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leading to lactate dehydrogenase leakage from cells. Autophagy results in formation of an 
autophagosome that could destroy major portions of the cytoplasm and organelles, with no 
nuclear chromatin condensation, no caspase activation or DNA degradation, mitochondrial 
and endoplasmic reticulum swelling (Ellis et al., 2010). From in vivo studies performed in 
mice, no autophagic response has been observed in mice heart ultrastructure. On the contrary, 
desulfated yessotoxin induced the clear appearance of small autophagosomes in a very short 
time, but the target organs were liver and pancreas, with no cardiac alteration (Terao et al., 
1990).  
Subsequent experiments were then performed on cardiomyocytes by propidium iodide uptake 
to detect dye-permeable necrotic cells. Cells were exposed for 5, 24, 48 and 72 h to increasing 
YTX concentrations (0.0001 up to 0.1 μM). Experiments showed a significant (p<0.01) 
increase of dye uptake after 24 h (0.01 µM), that was stronger at 48 h (p<0.001). No uptake 
was found after 5 h YTX exposure. These results are in contrast with those of Leira et al. 
(2002) in neuroblastoma cells, but are in agreement with a recent study performed in HepG2 
cell line (Young et al., 2009).  
The occurrence of apoptotic bodies with no detection of apoptosis is object of recent studies. 
It seems either that apoptotic pathways activated can be interrupted downstream by 
concomitant upregulation of endogenous caspase inhibitors and repressors, as well as by the 
lack of ATP needed to complete the active process of apoptosis. Moreover, this condition 
impairs cardiac contractile performance without myocytes drop-out. Another possible 
outcome of apoptosis interrupts is caspase-independent apoptosis, characterized by DNA 
cleavage into ~50 Kbp fragments much larger than the 200 bp fragments seen after 
conventional apoptosis. The critical mediators of caspase independent apoptosis are normally 
located in the mitochondrial intermembranous space and are released by permeabilization of 
outer mitochondrial membrane. Once released into the cytosol, these activators directly cause 
apoptosis by translocating from the cytosol to the nucleus where cause DNA fragmentation 
without caspase activation. This apoptosis way is thought to play significant roles in 
programmed cell death occurring with ischaemia-reperfusion and oxidant injury (Dorn, 2009). 
Thus, in cardiomyocyte culture, a first apoptotic feature such as nuclear apoptotic bodies 
could be followed by necrotic cell death correlated to the lost mitochondrial functionality. 
An additional experiment was performed on HL-1 atrial cardiomyocytes. Cells were 
exposed to the highest concentration of YTX employed in experiments (1 µM) and 
mitochondrial membrane potential was monitored as soon as incubation started up to 60 
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minutes. In this experimental system, no mitochondrial membrane potential depolarization 
was detectable. Previously, Bianchi et al. (2004) demonstrated an immediate and potent effect 
of YTX as a direct pore opener of mitochondrial permeability transition pore in both 
mitochondria isolated from adult rat livers and in intact MH1C1 Morris Hepatoma cell line. 
This could be tentatively explained because of cardiac myocytes constant fluctuations of free 
Ca
2+
: their mitochondria may adapt to become resistant to Ca
2+
 induction of the MPT. This 
adaptation may not occur in non excitable tissues such as liver, which is also vulnerable to 
MPT-dependent ischemia-reperfusion injury as well as heart (Lemasters et al., 2009). Results 
obtained show a high cytotoxicity in cardiomyocytes as well as a very cell specific response 
consequent to YTX exposure. The toxicological potential of this toxin needs to be further 
investigated to better understand the health risk to the humans. 
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SUMMARY 
 
Brevetoxins (BTXs) and ciguatoxins (CTXs) are two classes of algal neurotoxins produced by 
the dinoflagellates Karenia brevis and Gambierdiscus toxicus, and in humans are responsible 
of Neurotoxic Shellfish Poisoning and Ciguatera Fish Poisoning, respectively. Both 
intoxications are mainly characterized by neurological and gastro-intestinal symptoms and, in 
more severe cases, cardiovascular symptoms. Pharmacological studies have shown that 
molecular target for the CTXs and BTXs is the site-5 on the voltage-gated sodium channel 
(NaV). Toxin binding modifies channel activation and inactivation mechanisms to a terminal 
excitotoxicity and cell swelling via continuous sodium influx, membrane depolarization and 
spontaneous action potentials.  
NaV are responsible for action potential generation and propagation in excitable cells, playing 
a fundamental role in many higher processes such as cognition, cardiac conduction and 
sensitive perception. Mammalian NaVα-subunits have been identified in excitable tissues and 
named NaV1.1 through NaV1.9 as products of different genes and with different primary tissue 
distributions, cDNA sequences, protein structures, gating kinetics and pharmacological 
properties. This study focused on the NaV1.8 isoform, highly expressed in sensory dorsal root 
ganglion neurons and the NaV1.2 isoform, broadly expressed in neurons in the central nervous 
system, with the aim to better understand central and peripheral nervous system effects of 
these toxins in human poisoning episodes. The activity of BTXs (PbTx-1, PbTx-7, PbTx-3), 
and CTXs (P-CTX-1, C-CTX-1 and P-CTX-3C) was screened on the human embryonic 
kidney cell line (HEK293) stably expressing either NaV1.2 or NaV1.8 human isoforms. 
Cells were transfected by a chemical approach with NaVα subunits cDNA gene inserted in a 
TrueClone pCMV6-Neo plasmid and complexed in a liposome transfection reagent. The 
mRNA level analysis using Real Time PCR technique showed the specific presence of both 
isoforms only in transfected cells. Product specificity was confirmed by bio-sizing and 
sequencing techniques. The cytotoxic effects of neurotoxin BTX and CTX were assessed by 
exposing cells to increasing toxin concentrations in presence of the sodium channel activator 
veratridine and the sodium-potassium ATPase inhibitor ouabain. Results showed for BTX A 
and BTX B types, as well as for P- and C-CTX, a dose-dependent toxic effect on both HEK-
NaV1.2 and HEK-NaV1.8 clones while no observable effects were measured on the non-
transfected cells. For both clones, EC50 values of either P-CTX-1 and PbTx-7 were one order 
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of magnitude lower than those of other CTXs tested (10
-13
 vs 10
-12 
M) and other BTXs tested 
(10
-10
 vs 10
-9
 M). 
Overall the toxic response of the peripheral NaV1.8 to the polyether toxins was similar to that 
of the NaV1.2 suggesting the absence of a tissue selectivity of the polyether toxins for the 
peripheral channel. A better understanding of the particular sensory abnormalities associated 
to CFP and NSP will require further isoform studies.
  
 
 
 
 
INTRODUCTION 
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Brevetoxins chemical structure 
 
 
Brevetoxins (BTXs) are complex multi-ring methylated polyether neurotoxins produced by 
strains of the marine dinoflagellates Karenia brevis (formerly Ptychodiscus brevis or 
Gymnodinium breve). Two backbone type A and type B are known. The BTX type A 
backbone is formed by 10 contiguous ether rings (A-J) with the A-F and H-J rings forming 
two essentially independent planar portions of the backbone. This type can exist in solution in 
two stereochemical conformations relative to the G ring: a boat chair conformation and a 
crown conformation, with thermodynamics favouring the former. The BTX type B backbone 
consists of a long carbon chain forming 11 contiguous ether rings, all fused trans to one 
another. This ladder-like structure is essentially planar and rigid (Lin et al., 1981; Baden, 
1989).  
Both backbones originate a myriad of congeners (>15 toxins are known), including parent 
molecules and their biometabolites (figure 17). Initially, brevetoxins have been classified 
under several nomenclature that were unified by Poli et al. (1986) with the proposal for a 
unique notation system to correlate the toxins isolated from all the laboratories, with the 
numbering system proposed by Shimizu preceded by the letters PbTx denoting Ptychodiscus 
brevis toxin. As new brevetoxin metabolites are identified, the inclusion of the backbone type 
(type A or type B) in the nomenclature of brevetoxins has been more recently used. The 
brevetoxin chemical structures named with the 2 nomenclatures are reported in figure 16.  
Brevetoxin derivatives result from epoxidation across the double bond in the H-ring or 
derivatization at the C-37 hydroxyl in PbTx-2 (Baden et al., 2005). Some other natural 
brevetoxins isolated so far include PbTx-11, characterized by a shortened side chain, PbTx-
12, the only natural ketone brevetoxin known, and PbTx-tmb, PbTx-2 without the side chain 
tail. Other derivatives presumably non natural include PbTx-8, artefact of aqueous chloroform 
extraction of PbTx-2; PbTx-13 and -14, both believed to be extraction artefacts. 
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Figure 16: brevetoxin neurotoxins structure 
(Modified from Plakas and Dickey, 2009). 
 
Several biometabolites have been identified in shellfish and other living animals naturally or 
laboratory exposed to K. brevis brevetoxins. These metabolites included a desoxyBTX-B2, as 
well as glycinilcysteine, glutathione, and gamma-glutamylcysteine conjugates, and a series of 
fatty acids derivatives.  
 
 
 
Figure 17: Oxidative and conjugative pathways of B-type 
brevetoxin metabolism (rings H through K with R groups 
shown). 
(Modified from Radwan and Ramsdell, 2006). 
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Ciguatoxins chemical structure 
Ciguatoxins (CTXs) are a family of complex highly oxygenated cyclic polyether compounds 
produced by the benthic dinoflagellate of the genus Gambierdiscus spp which adhere to dead 
coral surfaces and bottom-associated algae (Bagnis et al., 1980). Toxins produced by algae 
are transmitted through marine food chain to herbivorous and carnivorous fishes, and 
ultimately to man (Vernoux et al., 1986). Gambierdiscus have been reported in Caribbean 
Sea, Indian and Pacific Ocean, (Pottier et al., 2002; Pottier and Vernoux, 2003) and more 
recently in the Western Africa Atlantic ocean and the eastern Mediterranean sea (Bentur and 
Spanier, 2007). Chemical structures of CTX have been found to vary with geographical origin 
(Vernoux and Lewis, 1997). Pacific Ocean ciguatoxins (P-CTX) and Caribbean ciguatoxins 
(C-CTX) have been isolated in different sources (Gambierdiscus spp., herbivorous or 
carnivorous fishes) and their structure determined (figure 18), whilst four Indian Ocean CTXs 
have been isolated and characterized, however their instability during late stages of 
purification did not allow their structural characterization (Lewis, 2006). P-CTX and C-CTX 
backbone consist of 13-14 contiguous ether rings trans-fused in a ladder-like manner (Lin et 
al., 1981; Shimizu et al., 1986; Murata et al., 1989; Satake et al., 1993; Satake et al., 1998). 
 
       Figure 18: Pacific and Caribbean ciguatoxin structure 
       (Lewis, 2006). 
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Ciguatoxins and brevetoxins share similar structure, with trans/syn-fused ether rings of 
various sizes (see figure 19), lacking in nitrogen, with similar molecular weight (~1112 vs 
~895, respectively) and common physical properties, in particular as non-polar compounds 
that are highly lipid-soluble.  
 
 
Figure 19: common structural feature of ladder 
shaped polyethers like brevetoxins, ciguatoxins 
and yessotoxin 
(Inoue et al., 2003). 
 
 
 
 
Brevetoxin and ciguatoxin intoxication 
Brevetoxins are transferred and accumulated in fish through marine food web 
(Flewelling et al., 2005; Naar et al., 2007) responsible for massive fish kills in the gulf of 
Mexico (Poli et al., 1986; Dortch et al., 1998; Dickey et al., 1999). Brevetoxins are also 
responsible for birds, marine mammal mortalities and other marine species (Dickey et al., 
1999; Trainer and Baden, 1999). Toxicity to humans is through a non-fatal foodborne illness 
named neurotoxic shellfish poisoning (NSP) that occurs after ingestion of shellfish (Johnson 
et al., 1985; Baden, 1989). Its symptoms include gastrointestinal effects, neurologic effects on 
both central and peripheral nervous system and cardiac effects. Gastrointestinal effects 
include abdominal pain and cramping, nausea, vomiting and diarrhoea. Common neurological 
symptoms include face, throat, fingers, toes and possibly total body paresthesias; ataxia; loss 
of coordination and/or balance; cramping limb pain; convulsions; paralysis; respiratory arrest 
up to coma; burning sensation of mucous membranes; distortion of oral and peripheral 
temperature sensation with reversal of temperature sensation (paradoxical dysaesthesia), i.e. 
warm drinks taste cold, a peripheral feeling like „cold rain‟ (Johnson et al., 1985; Sims, 1987). 
Only in most severe cases also disturbances of cardiac function have been reported, but 
usually intoxications are characterized by severe gastrointestinal disorders, paresthestia and 
locomotory problems, and no human fatalities have been reported so far (Baden, 1989; David 
et al., 2003). 
Other brevetoxins effects in humans are the consequence of skin exposure or through 
inhalation of aerosolized toxin formed from wave action during a red tide event. 
Consequences of inhalation are severe inflammatory response, with skin and upper-lower 
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airway irritation, with a non-productive cough, shortness of breath, bronchoconstriction, 
burning sensation of conjunctiva, rhinorrhea, sneezing, and eventually wheezing in persons 
predisposed to asthma (Huang et al., 1984; Lombet et al., 1987; Abraham et al., 2005). 
Ciguatoxins are responsible for ciguatera fish poisoning (CFP), a human seafood 
intoxication caused by the ingestion of contaminated fish species from tropical and 
subtropical coral reefs. Ciguatoxins are transferred from the benthos to herbivorous, 
macroalgae-feeding species (fish and invertebrates) and then to carnivorous fish via marine 
food web (Lewis and Holmes, 1993). Ciguatera is the most frequently reported toxin related 
seafood illness in the world, with at least 50,000 cases reported annually worldwide (Lewis, 
2001; Friedman et al., 2008). Onset of symptoms can vary from 30 minutes for severe 
intoxications to 24-48 hours and can be either gastrointestinal or neurological. 
Gastrointestinal symptoms include acute gastroenteritis (vomiting, diarrhoea, nausea and 
abdominal pain) only for a few days, while some neurological effects can take several days to 
develop. Ciguatera can last for several weeks to several months, in particular for peripheral 
neurologic symptoms, with a small percentage of cases (<5%) with symptoms persisting for 
years. Neurological symptoms occur within first days of illness, often becoming prominent 
after GI symptoms, particularly for C-CTXs. They include paresthesias (numbness, tingling), 
in extremities (lips, hands, feet) and oral region, generalized pruritus (itching), myalgia 
(muscle pain), arthralgia (joint pain), and severe feeling of fatigue. A distinctive symptom, as 
in NSP, is an alteration or reversal of hot/cold temperature perception, in which cold surfaces 
are perceived as hot to the patient, or dysesthesia (unpleasant abnormal sensation). Most 
severe intoxications develop cardiac symptoms with hypotension, bradycardia, respiratory 
difficulties and paralysis. Deaths are rare, probably because rarely do fish accumulate lethal 
CTXs levels at a single meal. Some patients develop allergy-like reactions to the consumption 
of certain proteinaceus food (fish, peanuts, chicken, pork) and alcohol, associated with re-
occurring ciguatera neurological symptoms (Lombet et al., 1987; Mattei et al., 1999; Lewis, 
2006; Friedman et al., 2008). 
Ciguatera intoxication differs in symptomatology depending on the geographical area of toxin 
production. Ciguatoxins from the Pacific Ocean cause more severe intoxication with 
predominantal neurological symptoms, including rare cases of coma and death (Hamilton et 
al., 2009). Ciguatera in the Caribbean Sea is characterized by gastrointestinal symptoms in the 
acute phase (i.e. 12 hours) with subsequent prominence of, mainly peripheral, neurologic 
symptoms. Ciguatoxins from Indian Ocean cause intoxication with neurological and mental 
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status alterations, with hallucinations, incoordination, loss of equilibrium, mental depression, 
nightmares. Ciguateric fish in Indian Oceans are also more frequently contaminated by lethal 
levels of CTXs (Lewis, 2006; Friedman, 2008). 
For both NSP and CFP there is no official treatment available, except for symptomatic 
therapies.  
 
Brevetoxins and ciguatoxins molecular target 
So far, in vitro studies have been performed and the interaction of both brevetoxins 
and ciguatoxins with voltage-gated sodium channel alpha subunit (NaV) has been well 
demonstrated. Neurotoxin site-5 on NaV was identified as the brevetoxin and ciguatoxin 
binding site, with toxins acting as competitive inhibitors. Structurally, site-5 is formed by 
transmembrane segments S6 and S5 of homology domains I (IS6) and IV (IVS5) of α-subunit, 
respectively (Lombet et al., 1987; Trainer et al., 1991; Trainer et al. 1994; Hogg et al., 1998; 
Dechraoui et al., 1999; Strachan and Nicholson, 1999). Toxin interaction with this receptor 
has been demonstrated to occur for brevetoxin molecule with a 1:1 stoichiometry PbTx-3:NaV 
(Trainer et al., 1991). 
Toxin binding to site-5 results in the prolonged depolarization of excitable membranes 
(cardiac cells, brain synaptosomes, nodose ganglia) and excitotoxicity by a) a shift in Na
+
 
channel activation potential in the hyperpolarizing direction leading to channel opening at 
membrane potential where they are normally closed; b) the prolongation of channel mean 
open times by a destabilization of inactivated conformation of the protein; c) the inhibition of 
fast channel inactivation process, by destabilization of inactivated conformation; and d) the 
occurrence of subconductance states in addition to the normal conducting state, with slowed 
kinetics of ion transport (Schreibmayer and Jeglitsch, 1992; Gawley et al., 1995; Jeglitsch et 
al., 1998). By increasing the sodium ion permeability of excitable cell membranes, toxins 
affect various sodium-dependent signalling processes such as neurotransmitter release (Bidard 
et al., 1984; Molgó et al., 1992). Binding of brevetoxins has been shown to be independent of 
membrane potential, binding equally well to both active and inactive channels (Poli et al., 
1986; Baden, 1989). In mammals, CTXs are the most potent NaV specific neurotoxin known, 
being similarly potent in mice by oral or i.p. administration (Lewis, 2006). Ciguatoxins 
affinity for sodium channels is at least 20-50 times higher than that of brevetoxins, and their 
effects are probably due to other cellular mechanisms than sodium channel modulation 
(Lombet et al., 1987; Gawley et al., 1992; Dechraoui et al., 1999). As such recent studies 
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demonstrated an inhibition of potassium channels at low nanomolar concentrations for 
ciguatoxins and related compounds (Hidalgo et al., 2002; Ghiaroni et al., 2005; Birinyi-
Strachan et al., 2005; Cuypers et al., 2008; Mattei et al., 2009; Schlumberger et al., 2009; 
Kopljar et al., 2009). 
On NaV both brevetoxins and ciguatoxins act as allosteric modulators. Toxins bind with high 
affinity to sites distinct from the pore or the voltage sensor and activate channels by shifting 
conformational equilibrium toward the activated state. Active brevetoxins share common 
structural requisites: a relatively rigid H-K ring thought to be involved in site binding; an 
electrophilic A ring, in most cases a 5- or 6-membered lactone (so called „head region‟); 
several ring „spacer regions‟ between these two sites; and a side chain called the „tail‟ located 
at the K-ring of the molecule (Rein et al., 1994; Baden et al., 2005). 
 
 
 
Figure 20: active brevetoxins structure 
features 
(Baden et al., 2005). 
 
 
 
 
Gawley et al. (1995) proposed the model of interaction between toxins and the open 
(conducting) conformation of the channel protein, with toxin head physically obstructing the 
normal motion of inactivation gate (IIIS6-IVS1 intracellular loop) that blocks ion conduction. 
Photoaffinity experiments showed the „tail‟ of brevetoxin B backbone lay next to S5-S6 
extracellular loop of domain IV. 
 
 
 
 
 
Figure 21: ‘head-down’ brevetoxin 
binding to VGSC site 5 model 
proposed by Gawley et al. (1995) 
(Baden et al., 2005). 
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Possible altered interactions of transmembrane segments within and between adjacent 
homologous domains, result in the alteration of voltage-gated activation and coupling to 
inactivation (Cestèle and Catterall, 2000). 
 
Brevenal, a derivative of brevetoxin, is characterized as an antagonist able to counteract the 
effect of brevetoxins (Purkerson-Parker et al., 2000; Bourdelais et al., 2004) and P-CTX-1B-
induced catecholamine release from chromaffin cells (Mattei et al., 2008; Nguyen-Huu et al., 
2009), opening the possibility to develop therapeutics to prevent or reverse brevetoxins 
intoxication. 
 
Brevetoxins and ciguatoxins in vitro effects 
The in vitro effects of brevetoxin and ciguatoxins have been well studied using on different 
tissue preparation and using a variety of methods.  
Brevetoxins induced in vitro effects include swelling of myelinated axons (Mattei et 
al., 1999), depolarization of nerves and muscle (Sasner, 1965; Shinnick-Gallagher, 1980; 
Huang et al., 1984; Richards and Bourgeois, 2010), repetitive firing in nerve cells 
(Westerfield et al., 1977; Parmentier et al., 1978; Shoukimas et al., 1979; Huang et al., 1984; 
Wu et al., 1985), increased release of catecholamine and acetylcholine transmitters (Ellis et 
al., 1979; Gallagher and Shinnick-Gallagher, 1980; Vogel et al., 1982; Risk et al., 1982; 
Atchinson et al., 1986), neuromuscular block (Baden et al., 1984), muscles fasciculation 
(Baden and Mende, 1982; Johnson et al., 1985), and ventricular fibrillation (Music et al., 
1973; Johnson et al., 1985).  
Ciguatoxins induced in vitro effects included swelling of myelinated axons (Mattei et 
al., 1999), the depolarization of muscle and neuroblastoma cells membrane (Rayner and 
Kosaki, 1970; Rayner, 1972; Bidard et al., 1984; Brock et al., 1995), of cardiac muscle 
(Lewis and Endean, 1986), the stimulated release of neurotransmitters such as GABA, 
dopamine and acetylcholine (Ohizumi et al., 1982; Molgó et al., 1992; Molgó et al., 1993; 
Bidard et al., 1984; Brock et al., 1995; Marquais and Sauviat, 1999; Sauviat et al., 2002; 
Mattei et al., 2009), contraction of the guinea pig vas deferens (Ohizumi et al., 1981) and 
ileum (Lewis and Endean, 1984; Lewis and Hoy, 1993), and positive chronotropy-inotropy in 
isolated atria (Ohshika, 1971; Miyahara et al., 1979; Lewis et al., 1992; Lewis and Hoy, 
1993). Inotropric effect on isolated guinea pig atria consists of two components, one indirect 
neurogenic action, at low concentration, through induction of noradrenaline release from 
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adrenergic nerve endings, and one direct myogenic action, at higher concentration, through 
direct interaction with sodium channels (Lewis and Endean, 1986; Seino et al., 1988). 
 
 
VOLTAGE GATED SODIUM CHANNELS 
 
Voltage gated sodium channels (NaV) form a family of membrane proteins expressed at low 
level in non-excitable cells such as glia, lymphocytes, osteoblasts, fibroblasts, endothelial 
cells, metastatic cancer cells of epithelial origin (Diss et al., 2004), and at higher level in 
excitable cells such as muscles (skeletal and cardiac), neurons (central nervous system, 
peripheral nervous system and sensory neurons), and neuroendocrine cells. NaV respond to 
depolarization of the membrane by opening a sodium ion-selective pore that permits ions flow 
down their electrochemical gradient into the cell, thereby contributing to the generation and 
conduction of action potentials (Shah et al., 2004, Chancey et al., 2007). For these reasons, 
NaV play an indispensable role in many higher processes such as cognition, cardiac 
conduction and locomotion and sensitive perception. Their physiological role in nonexcitable 
cells remains unclear (Catterall et al., 2005). 
 
 
Structure 
Voltage-gated Na
+
 channels are formed by one large α-subunit (220-260 kDa) and one or 
more smaller β-subunits (33-36 kDa). Pore-forming α-subunit is sufficient for channel 
functional expression, but kinetics, voltage dependence of channel gating and channel cellular 
localization are modified by auxiliary β-subunits (Catterall et al., 2002). 
The structure of α-subunit is organized in four homologous domains (I-IV), each containing 
six transmembrane α helices (S1-S6) and an additional membrane re-entrant pore loop (P-
loop) located between S5 and S6 segments, with internal and external connecting polypeptide 
loops. 
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Figure 22: NaV α-subunit structure 
(Cestèle and Catterall, 2000). 
 
 
Membrane re-entrant pore loops between S5 and S6 line the outer, narrow extracellular end of 
the pore, and each P-loop repeats and shares one critical residue forming a ring of four amino 
acid residues responsible for ion selectivity and permeation across the pore (Cestèle and 
Catterall, 2000; Sun et al., 2008). The inner wider intracellular end of the pore is formed by 
S6 segments. 
In each of the four domains, there is a S4 segment containing positively charged amino acid 
residues at every third position. These residues serve as gating charges and move outward 
under the influence of the membrane electric field when the membrane is depolarized, to 
initiate a conformational change that opens the pore (Catterall et al., 2007) through an 
activation gate hypothesized to be located at the cytoplasmic end of the S6 segments (Wang 
and Wang, 2003). A short intracellular loop connecting homologous domains III and IV 
serves as the inactivation gate, folding into the channel structure and blocking the pore from 
the inside during sustained depolarization of the membrane (Catterall et al., 2002). Both 
___  In trod uction  
72 
 
voltage sensors and inactivation gate are considered to be inaccessible to binding of 
hydrophilic polypeptide toxins (Catterall et al., 2007). 
 
Four auxiliary subunits of sodium channels have been defined thus far: NaVβ1, NaVβ2, 
NaVβ3, and NaVβ4, encoded by gene SCN1B, SCN2B, SCN3B and SCN4B, respectively. β 
subunits proteins contain a large N-terminal extracellular domain, a single transmembrane 
segment and a short C-terminal intracellular segment. β subunits proteins are fundamental for 
VGSC protein interaction with cell adhesion molecules, extracellular matrix proteins, and 
cytoskeletal linker proteins. They also enhance channel pore expression levels at plasma 
membrane and modulate its physiological properties (McCormick et al., 1999; Meadows and 
Isom, 2005). The molecular basis for sodium current diversity among the isoforms depends 
partly on subunit composition (Aman et al., 2009). 
 
 
Distribution and classification 
In mammals, at least nine isoforms (NaV-1.1 to NaV-1.9) of α-subunit have been characterized 
by cDNA cloning, sequencing and electrophysiological recording and functionally expressed. 
The majority of these subtypes are expressed in neurons, except for NaV-1.4 and NaV-1.5 
isoforms, typically expressed in skeletal and cardiac muscle, respectively. Proteins differences 
in amino acid sequences result in specialized electrophysiological function (e.g. single 
channel conductance) and pharmacological properties (e.g. sensitivity to pharmacological 
agents) (Catterall et al., 2002, 2007; Baden, 2005). 
All isoforms show greater than 50% identical amino acid sequence in extracellular domains, 
and greater than 70% amino acid sequence identity in their transmembrane segments (Goldin 
et al., 2000; Catterall et al., 2002; Catterall et al., 2007). NaV1.1, NaV1.2, NaV1.3, and NaV1.7 
are broadly expressed in neurones. NaV1.5, NaV1.8, and NaV1.9 are tetrodotoxin-resistant to 
varying degrees due to changes in amino acid sequence at a single position in domain I, and 
they are highly expressed in heart (NaV1.5) and dorsal root ganglion neurons (NaV1.8 and 
NaV1.9). Isoforms NaV1.4 is expressed primarily in skeletal muscle, and NaV1.6 is expressed 
primarily in the central nervous system. 
 
 
 
___  In trod uction  
73 
 
 
Table 4: 
Classification of voltage-gated sodium channel, names encoding the channels, auxiliary β 
subunits and primary tissue in which they are located  
(nd not determined) 
 
NaV α subunit 
(gene) 
Auxiliary 
subunits 
TTX 
Sensitivity 
tissue localization 
NaV1.1 
(SCN1A) 
β1-β2-β3 
+ 
(EC50 nM) 
CNS, cardiac myocytes, SA node 
NaV1.2 
(SCN2A) 
β1-β2-β3 
+ 
(EC50 nM) 
CNS, primarily un-, pre-myelinated axons 
NaV1.3 
(SCN3A) 
nd 
+ 
(EC50 nM) 
CNS, cardiac myocytes 
NaV1.4 
(SCN4A) 
β1 
+ 
(EC50 nM) 
skeletal muscle 
NaV1.5 
(SCN5A) 
β1-β2-β3 - cardiac myocytes 
NaV1.6 
(SCN8A) 
β1-β2 
+ 
(EC50 nM) 
cerebellum, hippocampus, Purkinje cells, 
astrocytes, Schwann cells, DRG, CNS nodes of 
Ranvier 
NaV1.7 
(SCN9A) 
β1-β2 
+ 
(EC50 nM) 
all types DRG neurons, sympathetic neurones, 
Schwann cells, neuroendocrine cells 
NaV1.8 
(SCN10A) 
nd - 
small & medium-sized DRG neurons and their 
axons 
NaV1.9 
(SCN11A) 
nd - 
c-type DRG neurones, trigeminal neurones and 
their axons 
 
 
Voltage-gated sodium channel and pain 
In sensory nerves, NaV mediates perception of touch, temperature and pain. Neuropathic pain 
results from damage to components of the nervous system such as primary afferent nerves, 
spinal cord, and central nervous system regions with altered electrical excitability of neurons 
(Ueda, 2006; Cummins et al., 2007). Its onset may be delayed after nerve injury, then pain 
sensation may persist after complete healing. Neuropathic pain is often characterized by 
stimulus-independent persistent pain, abnormal pain sensory perception as allodynia (pain 
sensation in response to innocuous tactile stimuli) and hyperalgesia (exaggerated pain 
sensation in response to mildly noxious stimuli) (Ueda, 2006). Nociceptors are located at 
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terminal of thinly myelinated Aδ-fiber and unmyelinated C-fiber of primary afferent neurons 
and transduce noxious chemical, mechanical or thermal stimuli into depolarizing currents that 
ultimately induce action potentials conducted to CNS (Ueda, 2006). NaV1.7 (tetrodotoxin 
TTX-sensitive), 1.8 and 1.9 (TTX-resistant) are the isoforms primarily expressed in 
nociceptive neurons (Liu et al., 2006). NaV1.7 play a crucial role in perceiving pain 
sensations, but seems to be not involved in proprioception, touch, warmth and cold (Cummins 
et al., 2007), whilst TTX-resistant NaV1.8-1.9 are both primarily expressed in the 
subpopulation of small-diameter unmyelinated nociceptive C-fibers of sensory neurons 
thought to be important in nociception (Ueda, 2006; Cummins et al., 2007). Unlike most 
neurones, small-diameter sensory neurons generate tetrodotoxin (TTX)-resistant action 
potentials and it has been shown DRG neurons from patients with neuropatic pain to be 
characterized by spontaneous action potentials insensitive to 300 nM TTX (Liu et al., 2006). 
Regarding NaV1.9 isoform, an up-regulation has been demonstrated during inflammation 
process and seems to be the isoform related to sensory neuronal hyperexcitability associated 
with inflammatory pain but doesn‟t play a major role in nerve injury-induced hyperalgesia 
(Liu et al., 2006). Studies on this isoform are difficult to perform because of its extremely 
difficult functional expression in heterologous expression systems (Cummins et al., 2007). 
NaV1.8 contribute substantially to the inward current underlying action potential of small-
sized DRG neurons, and it is likely TTX-R currents described in the majority of in vitro 
studies are conducted by NaV1.8 channels (Catterall et al., 2005; Liu et al., 2006; Cummins et 
al., 2007). NaV1.8 has a specialized role in nociceptors for perception of cold pain and pain in 
the cold, since at low temperatures NaV1.8 remains the only isoform producing action 
potential in nociceptors and NaV1.8-null mice show negligible responses to noxious cold and 
mechanical stimulation at low temperatures (Zimmermann et al., 2007). Moreover, NaV1.8 
isoform has a well demonstrated role in pain sensation. NaV1.8 is up-regulated in some 
models of inflammatory pain and NaV1.8-null mice exhibit delayed development of 
inflammatory hyperalgesia, reduced pain responses to noxious mechanical stimuli, and lower 
sensitivity in several models of visceral pain (Catterall et al., 2005; Liu et al., 2006) and in 
nerve-growth factor-induced thermal hyperalgesia (Liu et al., 2006). Antisense 
oligonucleotides NaV1.8 knockdown prevented hyperalgesia, reversed tactile and thermal 
allodynia induced by spinal nerve injury (Liu et al., 2006; Cummins et al., 2007) and 
decreased hyperalgesia induced by inflammatory agent prostaglandine E2 (PGE2) (Liu et al., 
___  In trod uction  
75 
 
2006). This in agreement with Liu et al. recent findings (2010) of PGE2 increased trafficking 
and protein level on cell surface of NaV1.8. 
 
 
Voltage-gated sodium channel neurotoxins 
The receptor sites on the α subunits of pharmacological agents and natural toxins acting on 
sodium channels have been identified (Catterall et al., 2005). Thus far, at least eight distinct 
receptor sites for neurotoxins and one receptor site for local anaesthetics and related drugs 
have been identified (Cestèle and Catterall, 2000; Wang and Wang, 2003) and their 
corresponding affect on the channel described (summarized in the the following table and 
figure). 
 
 
 
 
Figure 23: 
neurotoxins binding sites on Na
+
V α-subunit 
(Cestèle and Catterall, 2000). 
 
 
 
 
 
___  In trod uction  
76 
 
 
Table 5: 
receptor sites on voltage gated sodium channels α-subunit 
 
Receptor site Toxin or drug Domains Physiological effects 
Neurotoxin site 1 
tetrodotoxin and 
saxitoxin; 
μ-conotoxin 
IS2-S6, IIS2-S6, 
IIIS2-S6, IVS2-S6 
inhibition/block 
conductance 
Neurotoxin site 2 
veratridine; 
batrachotoxin; 
grayanotoxin; 
aconitine 
I-IVS6 
persistent activation, 
repetitive firing 
Neurotoxin site 3 
α-scorpion toxins; sea 
anemone toxins; 
spider toxins 
IS5-IS6, IVS3-S4, 
IVS5-S6 loops 
inhibition inactivation, 
enhanced persistent 
activation 
Neurotoxin site 4 β-scorpion toxins IIS1-S2, IIS3-S4 loop 
shifted activation, 
repetitive firing 
Neurotoxin site 5 
brevetoxins; 
ciguatoxins 
IS6, IVS5 
enhanced persistent 
activation, inhibited 
inactivation, repetitive 
firing 
Neurotoxin site 6 δ-conotoxins; nd 
enhanced persistent 
activation, repetitive 
firing 
Neurotoxin site 7 pyrethroids; DDT I, II and IIIS6 
persistent activation, 
depolarization of 
resting potential 
Neurotoxin site 8 Conus stratius toxin nd 
prolonged channel 
opening 
Site 9 
local anaesthetic, 
antiarrythmic, 
antidepressants and 
antiepileptic drugs 
IS6-IIIS6, IVS6 
inhibition of Na
+
 
permeability 
 
 
In vivo, ion channels do not exist in isolation but instead associate in complex with other 
plasma membrane, extracellular matrix and intracellular proteins that participates in cell 
adhesion, cytoskeletal anchoring and signal transduction. Molecular composition of a 
particular complex can have significant influence on channel function, localization and 
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cellular excitability. A given channel pore-forming subunit may behave very differently 
depending on its associated proteins (Meadows and Isom, 2005). However, when expressed in 
mammalian cells as heterologous expression systems, α-subunit alone can form functional 
voltage-gated Na
+
 channels with current kinetics and activation, ion selectivity, ion flow and 
inactivation processes comparable to their native counterparts (Wang and Wang, 2003; 
Chancey et al., 2007). 
The critical difference between in vitro and in vivo studies is channel expression in native 
cells: in their native environment voltage-gated sodium channel are targeted to specialized 
subcellular domains where they associate with specific signalling and structural proteins, and 
where they are exposed to second messengers. Co-expression of α- with β-subunits results in 
cell type-specific shifts in the voltage-dependence of activation and inactivation and in 
changes in channel modal gating behaviour with altered rates of activation, inactivation and 
recovery from inactivation. Channel expression at plasma membrane is increased (Meadows 
and Isom, 2005). 
  
 
 
 
AIM OF THE STUDY  
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Brevetoxins‟ and ciguatoxins‟ parent molecules and their metabolites are a suite of voltage-
gated sodium channel specific neurotoxins sharing a similar polyether chemical structure and 
mode of action. They are respectively responsible for two different human food-borne 
illnesses, Neurotoxic shellfish poisoning (NSP) and Ciguatera fish poisoning (CFP), 
characterized by particular peripheral neurological symptoms of distortion of oral and 
peripheral temperature sensation, with reversal of hot/cold temperature perception 
(paradoxical dysaesthesia) and diffuse pain syndrome. 
The voltage-gated sodium channels NaV1.8 in sensory neurons has a specialized role in 
nociceptors for perception of cold pain and a well demonstrated role in pain sensation 
(Zimmermann et al., 2007, Catterall et al., 2005; Liu et al., 2006; Cummins et al., 2007) and 
the P-CTX-3C was recently found to preferentially affect NaV1.8 than NaV1.2.  
This study proposed to further investigate those findings by comparing various polyether site-
5 neurotoxin potencies on the peripheral sensory neuron NaV1.8 isoform and the central 
neuron NaV1.2 isoform using a cytotoxicity assay. Toxins of choice were type A and type B 
brevetoxins, a Caribbean and two Pacific ciguatoxins. 
 
Plan of action: 
a) Create stable clones of human embryonic kidney cell line (HEK293) expressing NaV 
channels; 
b) Assess the relative potency of brevetoxins and ciguatoxins on NaV1.8 channel isoform and 
compare it to that on 1.2. 
 
  
 
 
 
MATERIALS & METHODS 
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HEK-293 cell line culture 
Human embryonic kidney cell line (HEK-293) was purchased from American Type Culture 
Collection (ATCC). Cultures were grown in a humidified atmosphere of 5% CO2, 95% air, at 37 
°C in Dulbecco‟s Modified Eagle Medium (DMEM) high glucose+GlutaMAX™-1 supplemented 
with 10% fetal bovine serum (FBS). Geneticin G418 antibiotic solution was also added to a final 
concentration of 500 µg/mL in the selective medium or to a final concentration of 250 µg/mL in 
the maintenance medium. At confluence, cultures were passaged by a rinse with PBS, detached 
with an incubation in a trypsin enzyme solution (TrypLE™ Express) for 10 minutes at 37 °C and 
subcultured in the same medium. For cytotoxicity assays, cells were harvested at 70-80% 
confluence. 
Clones were stored under liquid nitrogen in growth medium with 10% dimethyl sulfoxide 
(DMSO) and 20% FBS until use. Only cultures with passage number (<50) were used. 
 
Stable cell transfection 
To induce stable expression of either human NaV1.2 or NaV1.8, HEK cells were transfected with 
channel alpha subunits gene inserted in a TrueClone pCMV6-Neo plasmid. This expression 
vector has a Cytomegalovirus (CMV) promoter capable of driving heterologous gene expression 
in a variety of mammalian cell lines in culture and codes for the neomycin resistance gene 
allowing the growth in a selective medium to clones with a cDNA stably integrated in their 
genome. Plasmid DNA was dissolved in 100 µL of sterile deionized water to a final 
concentration of 100 ng/µL. The tube was let sit at 4 °C overnight, vortex mixed and used for the 
transfection the day after. Remaining solution was stored at -20 °C. 
The method of choice was a chemical transfection technique with artificial cationic liposomes 
which electrostatically associate to and cover nucleic acid negative charges. This complex results 
in a closer association of the DNA with the negatively charged cell membrane, followed by its 
endocytosis or fusion with the plasma membrane and its trapping in endosomes and lysosomes. 
How the DNA or the DNA/liposome complex enters into the nucleus is not yet known. 
Cells were seeded into 24-well plates to achieve 50% confluence 24 h (90.000 cells/cm
2
) or 48 h 
(50.000 cells/cm
2
) before the transfection day. Transfection mixture was prepared with serum-
free medium without antibiotics and pre-warmed at 37 °C by adding different amounts of DNA 
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(0.25, 0.5 and 0.75 µg/well) and the TransFast™ Transfection reagent (3.0 µL/µg DNA). The 
mixture was incubated for 15 minutes at room temperature (RT), briefly and gently vortex mixed 
and then used to replace the growth medium on the cells (200 µL/well). Cells were incubated for 
1 h at 37 °C in a 5% CO2 incubator, then overlaid with warm complete medium (1 mL/well) and 
let rest for 48 hours. Cells were then trypsinized and plated at increasing dilution factors (1:20 up 
to 1:500) into 60 mm Petri dishes with selective medium containing a concentration of geneticin 
(G418) founded to kill the 90% of the non transfected cells in 7 days (500 µg/mL). Medium was 
then changed every 3-4 days to remove cell debris and dead cells for about 14 days, until small 
clusters of 20-30 cells of each surviving clone were obtained. 
Each isolated growing clone was then subcultured into a 24-well plate in complete growth 
medium with a maintenance dose of G418 (250 µg/mL). From each transfection an average of 30 
geneticin-resistant clones were obtained and subcloned to finally select by N2a cytotoxicity assay 
the most sensitive one to 1 µM PbTx-3 for both NaV isoforms. 
 
RNA extraction and clean-up 
The integration of the plasmid was verified by the isolation of total RNA from the cells and the 
amplification of its complementary DNA (cDNA) by two step Real-Time Polymerase Chain 
Reaction (RT-PCR). 
Total RNA was isolated from confluent 75 cm
2
 flasks of both transfected and non transfected cell 
lines using TRI Reagent
®
 isolation reagent. Flasks were rinsed with PBS and trypsinized as 
routine culture protocol, and trypsin enzyme was stopped by the addition of warm complete 
medium. Cell suspension was centrifuged (Thermo IEC Centra CL2, Thermo Fisher Scientific 
Inc.) at 170g for 1 minute at RT and supernatant was discarded. Cells pellet was then re-
suspended in a 15 mL tube with TRI Reagent (2 mL/confluent 75 cm
2
 flask), mixed and 
incubated at RT for 5 minutes. Chloroform was added (0.4 mL/tube), shaked for 15 times and let 
sat at RT for 2 minutes. Tubes were then centrifuged (Thermo Electron Corporation, IEC 
MultiRF centrifuge) at 12,000g for 15 minutes at 4 °C and supernatant was then transferred into a 
pre-chilled RNase/DNase free microcentrifuge tube to add isopropanol (0.5 mL/tube) to 
precipitate RNA, vortex mixing briefly. Then, either RNA extraction was stopped and samples 
were stored at -80 °C, or continued after sat samples for 5 minutes at RT. Supernatant obtained 
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by centrifugation at 12,000g for 8 minutes at 4 °C (Eppendorf centrifuge 5417R) was discarded 
by vacuum aspiration and the RNA pellet was washed by vortex mixing with 1 mL of cold 75% 
ethanol and centrifuged again at 7,500g for 5 minutes at 4 °C. Ethanol wash was removed and the 
pellet was air-dried for 10 to 15 minutes. RNase-free water (100 µL) supplemented by Rnasein 
inhibitor (0.8 µL) was then added to each tube to dissolve the pellet. 
RNA clean-up was performed with Qiagen‟s RNeasy Mini Kit. According to manufacturer 
protocol, buffer RLT was added to each tube (350 µL), mixing and adding 100% ethanol (250 
µL/tube), and mixed by pipetting. Samples were collected into columns and spin at 8,000g for 15 
seconds, flow-through was discarded and buffer RW1 was then added (350 µL), to spin as above. 
Flow-through was discarded and DNase I incubation mix (10 µL DNase I stock solution into 70 
µL buffer RDD) was added directly to the columns and left at RT for 15 minutes to remove 
genomic DNA. Buffer RW1 (350 µL/column) was then added and centrifuged at 8,000g for 15 
seconds, flow-through was discarded, buffer RPE was added (500 µL/column) and spun as 
previously described, flow through was damped and buffer RPE was added to spin at 8,000g for 
2 minutes. Flow-through was discarded and samples were centrifuged at 8,000g for 1 minute. 
Columns were placed in new collection tubes, nuclease free water (30 µL/column) was added and 
let stand 1 minute. Samples were spun at 8,000g for 1 minute, water was then added again to 
repeat the spin. Clean RNA extracted was quantified with 2 µL samples by a NanoDrop ND-1000 
spectrophotometer (3.3 software version). Samples were stored at -80 °C until reverse 
transcription. 
 
Reverse transcription 
Total RNA samples were diluted in nuclease-free water to a final RNA concentration of 500 
ng/μL. Complementary DNA template for PCR amplification was synthesized with 
RETROScript
®
 kit as follows: for each sample, 500 ng of RNA extracted were placed in a tube, 
adding oligo(dT) primers (50 μM, 2 μL/tube) and bringing to a final volume of 12 μL with 
nuclease-free water. Tubes were heated at 70-85 °C for 3 minutes to heat denature the RNA to 
remove secondary structure, and then placed on ice. 10X RT buffer (500 mM Tris-HCl, pH 8.3, 
750 mM KCl, 30 mM MgCl2, 50 mM DTT) (2 μL/tube), 4 deoxynucleotide triphosphates mixed 
(2.5 mM each, 4 μL/tube), RNase inhibitor (10 units/μL, 1 μL/tube) and Moloney murine 
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leukemia virus (MMLV) reverse transcriptase (100 units/μL, 1 μL/tube) were added to the tubes 
and mixture was incubated at 42-44 °C for 1 hour. Tubes were then incubated at 92 °C for 10 
minutes to inactivate the reverse transcriptase and stored at 4 °C until use.  
 
Real Time PCR 
Primers sequences for RT-PCR were the same as reported by Yarowsky et al. (1991) for HEK-
NaV1.2 clone (named as primer pair B) and by Jo et al. (2004) for HEK-NaV1.8 clone and are 
summarized in table 6. Sequences were synthesized by IDT, Integrated DNA Technologies. 
Oligonucleotides were dissolved in nuclease-free water up to a 100 µM final concentration and 
used without further purification. 
Experiments were conducted in triplicate for each clone, HEK control cell line and a no template 
control to exclude a DNA contamination in the PCR reagents. Power SYBR Green PCR Master 
Mix (25 µL), nuclease-free water (21 µL), primer pair (2 µL, prepared by mixing 80 μL of 
nuclease-free water and 10 μL of each primer solution) and either the cDNA template or 
nuclease-free water for the no-template control (2 µL) were added to each tube in this order. 
As shown in figure 24, PCR was run with an initial heat denaturation at 95 °C for 10 minutes 
(stage 1), followed by cooling to 94 °C for 15 seconds and to 60 °C for 40 seconds to anneal 
template and primers, finally heating to 72 °C for 1 minute for optimal amplification, repeated 40 
times (stage 2). Final dissociation was then performed by heating to 95 °C for 15 seconds, 
cooling to 60 °C for 1 minute and re-heating to 95 °C for 15 seconds (stage 3). RT-PCR was 
performed with an Applied Biosystems 7500 Real-Time PCR System. 
 
 
Figure 24: Real Time PCR settings for HEK-NaV1.2 and HEK-
NaV1.8 clones 
 95°C 94°C 
72°C 
95°C 
60°C 
0’15’’ 
0’40’’ 
1’00’’ 
0’15’’ 10’00’ 
(stage 1) 
40 cycles (stage 2) 
60°C 
1’00’’ 
95°C 
0’15’’ 
∞ 
4°C 
            (stage 3) 
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CHANNEL SIZE (bp) SEQUENCE (5’-3’) 
Nav1.2 626 
Forward: CATTCCTCCAGAGATGGTGTC 
Reverse: TTCATGGGCAACCTGAGGAATA 
Nav1.8 453 
Forward: CTTGGGCTTTCCTCTCACTG 
Reverse: AGGCGAGGCCIAGAAAAGAC 
 
Table 6: primers used for Real Time PCR amplification of 
NaV1.2 and NaV1.8 genes 
 
 
Real Time PCR products bio sizing and quantification 
RT-PCR products were size-fractionated and quantified by an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Waldbronn, Germany) with Agilent DNA 1000 reagents. DNA dye concentrate 
and DNA gel matrix mixture were prepared according to manufacturer‟s protocol and stored at 4 
°C in the dark up to 4 weeks. The DNA chip was loaded with gel-dye mix (9 µL) at the bottom of 
the first well marked „G‟ and pressurized with the appropriate syringe for 60 seconds. After 5 
seconds gel-dye mix was pipetted in each of the wells marked. DNA marker (5 µL) was pipette 
into both ladder and samples wells, adding then 1 µL of either DNA ladder or sample. Chip was 
then vortex mixed at 2400 rpm for 1 minute and the run started within 5 minutes into the Agilent 
2100 Bioanalyzer (Version A.02.12 SI292). 
 
Real Time PCR products clean up 
PCR products were cleaned for sequencing with the QIAquick
® 
PCR Purification kit. For each 
sample, 60 µL of PCR product were mixed with 5 volumes of Buffer PB (300 µL) into a spin 
column in a collection tube to spin at 17,800g, for 45 seconds at RT (Eppendorf centrifuge 
5417R). Flow-through was discarded and tubes were spun as above again after the addition of 
Buffer PE (750 µL) to wash. Flow-through was discarded and tubes were spun again as before 
for 1 minute. Columns were then placed in new 1.5 mL microcentrifuge tubes and nuclease-free 
water (50 µL/tube) was added directly to each membrane and samples were spun as above to 
elute DNA. 
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Real Time PCR products sequencing 
HEK-NaV1.2 clone cDNA product and relative primers were shipped to SeqWright DNA 
Technology Services (SeqWright Inc., Houston, TX, USA, www.seqwright.com) for sequencing. 
 
Cytotoxicity assay 
The cytotoxicity assay consists of exposing cells to NaV modulator toxins in presence of both 
veratridine and ouabain. Veratridine was prepared as 1 mM stock solution in pH 2 water and 
ouabain was prepared as 10 mM stock solution in water and kept protected from light. Both 
solutions were sterilized by filtration and stored at 4 °C for no longer than 10 weeks. Toxins were 
serially diluted in 100% methanol to concentrations ranging from 100 μg/mL to 0.001 μg/mL for 
brevetoxins (PbTx-1, PbTx-3 and PbTx-7) and from 1 ng/mL to 0.000001 ng/mL for ciguatoxins 
(P-CTX-1, C-CTX-1 and C-CTX-3C) and stored at -20 °C. 
Cells were seeded in 96-well plates (40.000 cells/well) in DMEM+GlutaMAX™-1 supplemented 
with 10% FBS (100 µL/well) 24 hours before starting the exposure to the toxins to reach 50-70% 
confluence. Incubation started adding to each well both veratridine (50 µM for HEK-NaV1.2 
clones and non transfected cells, 100 µM for HEK-NaV1.8 clones) and ouabain (0.05 µM), 
followed by the addition of serially diluted toxins stock solutions (1 µL/well) or of 100% 
methanol (1 µL/well) to vehicle control wells. After 24 hours of exposure cell viability was 
estimated with the CellTiter 96
®
 AQueous One Solution Cell Proliferation Assay added directly to 
each well (20 µL/well) and incubated for 3 hours at 37 °C. Absorbance of produced formazan 
crystals was measured at 544 nm wavelength by an automated microplate-based plate reader 
FLUOstar spectrophotometer (BMG Labtechnology).  
Each experimental point was run in duplicate and repeated two-six times. 
 
Amino acid sequences comparison 
Clones NaV alpha subunit amino acid sequences were compared to each other as well as to the 
putative brevetoxin receptor site 5 sequences identified by Trainer et al. (1994). 
Amino acid sequences for both clone alpha subunit isoforms were obtained from mRNA 
accession number by a nucleotide Megablast (blastn) and sequences were compared by a protein-
protein BLAST (blastp) with NCBI Blast (www. http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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Data analysis 
 
Results were graphed with GraphPad Prism version 4.0 (GraphPad Software Inc., San Diego, 
CA, USA). RT-PCR products were automatically size-fractionated and quantified by an Agilent 
2100 Bioanalyzer (Version A.02.12 SI292).  
Data from cytotoxicity experiments were analyzed as absorbance raw values by sigmoidal 
concentration-response curve regression with GraphPad Prism software. Values of 50% effective 
concentration (EC50) from cytotoxicity curves were then determined as mol/L for each 
experiment and data are reported as means ±standard deviations (SD). Student t-test was 
performed to calculate p values. 
 
 
Chemicals 
 
Agilent Technologies (Waldbronn, Germany): Agilent DNA 1000. 
Applied Biosystems/Ambion
® 
(Austin, TX, USA): RETROScript
®
 kit, Power SYBR Green 
PCR Master Mix. 
Costar (Cambridge, MA, USA): 24- and 96-well tissue culture plates, 60 mm Petri dishes, 75 
cm
2
 flasks. 
Gibco BRL/Life Technology (Carlsbad, CA, USA)–Grand Island, NY: DMEM high 
glucose+GlutaMAX™-1, FBS, TrypLE™ Express. 
IDT Integrated DNA Technologies, Inc. (Coralville, IA, USA): NaV1.2 and NaV1.8 α-subunits 
primer pairs. 
Promega (Madison, WI, USA): TransFast™ Transfection reagent, CellTiter 96® AQueous One 
Solution Cell Proliferation Assay. 
Sigma Chemical Company (St Louis, MO, USA): G418 disulfate salt solution, DMSO, 
veratridine, ouabain, chloroform, isopropanol, ethanol, methanol. 
Origene (Rockville, MD, USA): TrueClone™ human full-length cDNA clones: accession 
numbers NM_021007.1 (human 1.2 alpha subunit) and NM_006514.2 (human 1.8 alpha subunit). 
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Molecular Research Center, Inc (Cincinnati, OH, USA): TRI Reagent
®
-RNA/DNA/protein 
isolation reagent. 
QIAGEN Sciences (Maryland, USA): RNeasy
®
 Mini Kit, QIAquick
® 
PCR Purification kit. 
Calbiochem-Novabiochem Corporation (La Jolla, CA, USA): Brevetoxins PbTx-1, PbTx-3 
and PbTx-7. 
 
Other toxins employed in this study: P-CTX-1 was purchased from Doctor Richard Lewis 
(Institute for Molecular Bioscience, The University of Queensland, Brisbane, Qld 4072, 
Australia), C-CTX-1 was generously given by Doctor Robert Dickey (US FDA) and P-CTX-3C 
was a kind gift of Professor Takeshi Yasumoto (Tama Laboratory, Japan Food Research 
Laboratories, Tama, Tokyo, Japan).  
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Expression of NaV1.2 and NaV1.8 VGSC alpha subunit mRNA in HEK clones 
 
 
Real time PCR 
 
Real Time PCR performed on the two clones and on non-transfected HEK-293 cells 
demonstrated the selective mRNA production of both VGSC isoforms in transfected cells. 
Figure 25 shows for each sample the corresponding threshold cycle (Ct) value, a measure of 
the cycle number at which the fluorescent signal of the reaction crosses the threshold, 
becoming statistically significant with respect to the calculated baseline signal. Ct value is 
inversely related to the amount of starting template. Ct values had an average of 23.85 ±0.32 
cycles for the NaV1.2 clone and 16.64 ±0.37 cycles for the NaV1.8 clone. The non-transfected 
HEK-293 control cell line had Ct values of 32.74 ±1.23 cycles for the 1.2 VGSC alpha 
subunit and 37.92 ±1.41 cycles for the NaV1.8 alpha subunit, suggesting a very low specific 
mRNA expression or a non-specific product amplification in these samples. 
 
 
Figure 25: Real Time PCR analysis of NaV1.2 and NaV1.8 
alpha subunit mRNA synthesis in transfected and non-
transfected cells. 
Data are reported as corresponding threshold cycle (Ct) values 
(means ±SD, n=3) of PCR-amplified samples. 
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Real Time PCR products bio sizing and quantification 
 
Complementary DNA size-fractionation showed products with a size of 566 bp, at a 
concentration of 1.5 ng/µL for the NaV1.2 VGSC clone and of 427 bp, at a concentration of 
5.8 ng/µL for the NaV1.8 VGSC clone cDNA. These values are similar to the size expected 
for both isoforms, reported to be 626 bp and 453 bp, respectively, for the NaV1.2 and NaV1.8 
isoforms (Yarowsky et al., 1991; Jo et al., 2004) (see figure 26). 
 
 
Figure 26: cDNA products bio sizing 
Results are visualized as a band of cDNA product (right lanes) 
for which the size, in bp, is estimated using the standardized 
ladder bands (left lanes). 
 
 
Real Time PCR product sequencing 
 
The HEK-NaV1.2 clone cDNA product as analyzed by Seqwright DNA Technology Services 
(Houston, TX, USA) showed a maximum identity of 93 % (by forward primer) and 94 % (by 
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reverse primer) with Mus musculus voltage gated type II alpha1 (Scn2a1) sodium channel 
subunit mRNA (accession number NM_001099298.2). 
 
 
Brevetoxin and ciguatoxin toxicity on HEK-NaV1.2 and -NaV1.8 clones and on HEK-non 
transfected cells 
 
Dose-response curves 
 
The relative potencies of ciguatoxins and brevetoxins on NaV were assessed by a cytotoxicity 
assay using cell viability as an end point. The cells were exposed overnight to the site-2 
sodium channel activator veratridine and the Na
+
/K
+
 ATPase pump inhibitor ouabain in the 
presence of increasing concentrations of neurotoxins, ranging from 0.001 µM up to 100 µM 
for the BTXs (PbTx-1, PbTx-7 and PbTx-3), or from 0.000001 µM up to 1 µM for the CTXs 
(P-CTX-1, P-CTX-3C and C-CTX-1). The most toxic response to the polyether toxins was 
obtained with a ouabain concentration of 0.05 μM, along with the addition of veratridine at 
final concentration of 50 μM for HEK-NaV1.2 and 100 μM for HEK-NaV1.8. Figure 27 
represents the toxin cytotoxicity on HEK-NaV1.2 (figure 27A) and HEK-NaV1.8 (figure 27B) 
reporting the toxin concentration as Log10 g/mL on X axis, and the cell viability expressed as 
a percentage of ouabain/veratridine treated control cells on Y axis. Data were best fitted using 
a sigmoidal regression curve with a slope of 1. The maximum cell death observed, estimated 
by the bottom value of the curve, of the ouabain-veratridine treated control cells averaged at 
~26% with HEK-NaV1.2 and ~31% with HEK-NaV1.8. On the other hand, no reduction in cell 
viability was observed when non-transfected cells were incubated with ouabain (0.05 μM), 
veratridine (50 μM) and toxin concentration ranging from 0.001 µM up to 100 µM for the 
BTXs (PbTx-1, PbTx-7 and PbTx-3), or from 0.000001 µM up to 1 µM for the CTXs (P-
CTX-1, P-CTX-3C and C-CTX-1) (figure 28). 
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Figure 27: CTXs and BTXs cytotoxicity on (A) HEK-NaV1.2 
and (B) HEK-NaV1.8 
Data are reported as mean ±SD. Viability is expressed as the 
percent absorbance of viable cells relative to ouabain/veratridine 
control (n=6). Each experimental point was run in duplicate 
wells and repeated two to four times.  
EC50 values for each curve are reported in table 7. 
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Figure 28: CTXs and BTXs cytotoxicity on non-transfected 
HEK-293 cells 
Data are reported as mean ±SD. Viability is expressed as percent 
absorbance of viable cells relative to ouabain/veratridine 
control. Each experimental point was run in duplicate. 
 
 
Comparison of brevetoxin and ciguatoxin EC50 values in NaV1.2 and NaV1.8 clones 
 
The effective concentration at 50 % (EC50) values for the CTX and BTX treatments for both 
HEK clones are reported in the table 7. Values compared by Student t-test found a significant 
difference between P-CTX-1 and both C-CTX-1 (p<0.05) and P-CTX-3C (p<0.001), and 
between PbTx-1 and both PbTx-3 (p<0.05) and PbTx-7 (p<0.01) in the HEK-NaV1.2 clone. A 
significant difference was found between P-CTX-1 and C-CTX-1 (p<0.05) and between 
PbTx-7 and both PbTx-1 and PbTx-3 (p<0.05) in the HEK-NaV1.8 clone. In both NaV1.2 and 
NaV1.8 clones, the most potent CTX was P-CTX-1 with EC50 values ~5-fold lower than that 
of C-CTX-1 and ~8-fold lower than that of P-CTX-3C. Similarly, the most potent BTX was 
PbTx-7 with EC50 values 7-fold lower than PbTx-1 and ~3-fold lower than PbTx-3. 
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 HEK-NaV1.2 HEK-NaV1.8 
 EC50 relative 
potency 
EC50 relative 
potency 
P-CTX-1 4.81 x 10
-13
 (±1.89 x 10
-13
) 1 4.60 x 10
-13 
(±1.63 x 10
-15
) 1 
C-CTX-1 2.69 x 10
-12 
(±1.55 x 10
-12
) 5.8 * 1.75 x 10
-12 
(±7.37 x 10
-13
) 3.9 * 
P-CTX-3C 4.67 x 10
-12 
(±5.30 x 10
-13
) 9.7 *** 3.27 x 10
-12 
(±2.24 x 10
-12
) 7.1 
PbTx-1 7.73 x 10
-9 
(±1.73 x 10
-9
) 7.4 *  3.86 x 10
-9 
(±3.53 x 10
-9
) 7.0 * 
PbTx-3 2.73 x 10
-9 
(±1.99 x 10
-9
) 2.7  1.76 x 10
-9 
(±4.83 x 10
-10
) 3.3 * 
PbTx-7 1.04 x 10
-9 
(±8.41 x 10
-10
) 1 5.48 x 10
-10
(±3.18 x 10
-10
) 1 
 
Table 7: Summary of toxin potency on HEK-NaV1.2 and HEK-NaV1.8 
VGSC clones 
Data are reported as mean ±SD of molar EC50 values obtained by sigmoid 
curve regression of experiments performed in duplicate, repeated two to 
six times. Averaged values were compared as relative P-CTX-1 potency vs 
both C-CTX-1 and P-CTX-3C, and PbTx-7 vs both PbTx-1 and PbTx-3. 
* p<0.05; *** p<0.001 (Student t-test). 
 
 
Amino acid sequences comparison 
 
Amino acid sequences of the alpha subunit clones were compared by NCBI Blast to the two 
putative brevetoxin receptor site 5 sequences identified by Trainer et al. (1994) on VGSC 
domain I and domain IV. Figure 29 reports data on the Y axis as score bits to compare 
alignment scores from different searches, and on the X axis the name of the single domain 
compared to each alpha subunit. 
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Blast system significance is reported as expectation value E: the lower the E value, the more 
significant the score. NaV1.2 sequence showed an identity of 97 % (E=3e-55, 197 score bits) 
with the domain I sequence and an identity of 94 % (E=1e-57, 206 score bits) with the domain 
IV sequence. The 1.8 VGSC alpha subunit sequence showed an identity of 71 % (E=2e-40, 
148 score bits) with the domain I sequence and an identity of 74 % (E=1e-42, 156 score bits) 
with the domain IV sequence. 
 
Figure 29: Comparison between alpha subunits and putative 
brevetoxin receptor site 5 amino acid sequences. Values were 
calculated by NCBI blast system and reported as score bits. 
 
 
 
  
 
 
 
 
DISCUSSION 
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The typical sensory abnormalities observed in CFP particularly in the Pacific suggest that the 
site-5 neurotoxins may have a unique interaction with voltage gated sodium channel (NaV) 
isoforms from sensory neurons. In this study we have examined the effects of three 
ciguatoxins (P-CTX-1, P-CTX-3C and C-CTX-1) and three brevetoxins (PbTx-1, PbTx-7, 
and PbTx-3) on the peripheral sensory neuron NaV1.8 isoform and compared it to that on the 
central nervous NaV1.2 isoform. 
Human embryonic kidney (HEK) cells were transfected by a chemical approach with 
NaVα-subunits cDNA gene however without the auxiliary NaVβ-subunit, and two stable cell 
lines expressing either NaV1.2 or NaV1.8 were successfully constructed to conduct this study. 
Real time-PCR analysis confirmed the expression of specific NaV1.2 or NaV1.8 mRNA in the 
two HEK stable cell line produced while a very low or non-specific mRNA product 
amplification was measured in non transfected HEK cells. It is worth noting that since the 
primer pair used for NaV1.2 had broad-selectivity for the four brain isoforms NaV1.1, NaV1.2, 
NaV1.2a and NaV1.3, which confirms the previous report of their absence in HEK cell line 
(Liu et al. 2006).  
Toxin potencies and thus evaluation of NaV functionality in the two clones were 
assessed using a cytotoxicity assay that was first described for mouse neuroblastoma N2a 
cells (Kogure et al. 1988), and successively modified (Jellett et al., 1992; Manger et al., 1993, 
1995; Dickey et al., 1999) and adapted to the HEK cell line as an heterologous system for 
high copy stably expressed homologous target receptors (Fairey et al., 2001). Using this 
method, the best toxic response to the polyether toxins was obtained with a ouabain Na
+
/K
+
 
ATPase pump inhibitor concentration of 0.05 μM, along with the addition of site-2 sodium 
channel activator veratridine at final concentration of 50 and 100 μM for HEK-NaV1.2 and 
HEK-NaV1.8, respectively. As previously reported (Fairey et al., 2001; Bottein Dechraoui and 
Ramsdell, 2003) the HEK clones appeared highly sensitive to ouabain which was used at 
concentration four order magnitudes lower than that used in the original neuroblastoma cells 
assay. The use of a higher veratridine concentration for the HEK-NaV1.8 clone was also in 
agreement with other studies showing a reduced sensitivity of the rat NaV1.8 to veratridine 
relative to the rat NaV1.2a or the human NaV1.5 expressed in F-11, CHO and 293-EBNA 
cells, respectively (Vickery et al., 2004), and a lower agonist effect of veratridine on human 
NaV1.8 than NaV1.5 and NaV1.7 (Liu et al., 2006).  
Overall our assay condition resulted in a low to moderate reduction of cell viability 
(with an averaged maximum loss of ~26% with HEK-NaV1.2; and ~31% with HEK-NaV1.8). 
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Yet the observed dose-dependent cytotoxic effect confirmed the presence of NaV proteins at 
the cell membranes and revealed the susceptibility of both the peripheral and the central 
sodium channel isoforms to the polyether toxins. Further analysis of the sigmoidal dose-
response parameters revealed similar toxin‟s relative potencies within the two clones. Among 
the three ciguatoxins backbone tested (i.e. type 1 and 2 Pacific CTX P-CTX-1 and P-CTX-3, 
respectively and a Caribbean CTX the C-CTX-1), the P-CTX-1 appeared the most potent 
while no significant differences in the EC50 values were observed within the C-CTX-1 and the 
P-CTX-3C. Among all brevetoxins tested the type A alcohol brevetoxin (PbTx-7) was the 
most potent with an EC50 value 7-fold lower than its parental type A aldehyde (PbTx-1), and 
3-fold lower than its corresponding type B alcohol (PbTx-3), in both HEK-NaV1.2 and -
NaV1.8 clones.  
Along with previous study of the effects and affinity on NaV to a wide panel of 
polyether toxins and their newly discovered metabolites the new results provided here are 
providing useful information to better assess toxin‟s structure-activity relationship. As such, 
the hydroxyl groups at the extremities of the CTX molecule are proposed to promote a more 
stable interaction with binding site (i.e. by creation of hydrogen bonds within the binding 
site), although structural differences at the CTX M-ring may lead to slight differences in 
potency indicating that the ring contributes to, but is not critical for, high affinity binding to 
NaV (Lewis et al., 1993). As well Dechraoui et al. (1999) reported that ciguatoxins affinity 
and toxicity seemed related to hydroxylation of the A-ring. For the brevetoxins, the important 
role shown in this study is the polarity induced by the hydroxyl group on the K-ring side-
chain on toxin potency which confirms previous findings comparing the BTX type B alcohol 
(PbTx-3) with its aldehyde parental (PbTx-2) toxin (Gawley et al., 1992; Poli et al., 1986; 
Bottein Dechraoui and Ramsdell, 2003; Bottein Dechraoui et al., 2006; Cao et al., 2008, 
Atchinson et al. 1986). As well, our result confirms the lower potency of the more rigid type 
B brevetoxin backbone observed by others (Baden et al., 1988; Gawley et al., 1992; Cao et 
al., 2008). 
 
An additional level of understanding of CTXs and BTXs interaction with their 
molecular binding site is provided by comparative studies of site-5 toxins‟ activity within NaV 
isoforms. Different primary and/or tertiary protein structure can greatly alter ligand 
interaction with the channel and small changes such as a single amino acid substitution have 
been shown to importantly affect neurotoxin site affinity/sensitivity of an isoform to ligand 
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toxins (Satin et al., 1992; Favre et al., 1995; Cummins et al., 2002; Xue et al., 2003; 
Haverinen et al., 2007), although high identity among isoforms does not always implicate the 
same or similar sensitivity (Denac et al., 2002). Within the putative brevetoxin receptor 
binding site identified by Trainer et al. (1994) on the NaV, the primary structure of NaV1.2 
respectively shows 91%, 76% and 74% identities against NaV1.4, NaV1.5 and NaV1.8 (NCBI 
blast). Hence, a previous study comparing site-5 toxins‟ relative potency and affinity on 
NaV1.4, 1.5 and 1.2 reported a tissue selectivity of the BTX type B PbTx-3 and PbTx-2 which 
was found neither for the BTX type A PbTx-1 nor the CTX P-CTX-3C (Dechraoui and 
Ramsdell, 2003); BTX type B toxins were showing a uniquely lower affinity and toxicity for 
the cardiac NaV1.5 sodium channel. These findings were consistent with electrophysiological 
recordings using a patch clamp method and P-CTX-3C on the three isoform NaV1.2, NaV1.4 
or NaV1.5 isoforms (Yamaoka et al. 2004, 2009).  
In the present study, the direct comparison of the susceptibility of the HEK-NaV1.8 to 
-NaV1.2 to the site-5 toxins was limited by the probable variation in receptor expression level 
and the fact that the assay conditions were different for the two clones. Nonetheless the EC50 
values for each toxin were similar for both clones (in the low pM range for CTXs and low nM 
range for BTXs) which was not in agreement with the electrophysiological recent findings 
from Yamaoka (2009) showing a greater effect of the P-CTX-3C on the rat NaV1.8 
(transiently expressed in ND7-23 cells) compared to that on NaV1.2 and 1.4 (transiently 
expressed in HEK). These divergent observations could reside in the expression of a 
dysfunctional sodium channel. Indeed in the 2009 Yamaoka et al. studies, NaV1.8 in HEK 
cells were found not functional whilst two chimeric mutants from both NaV1.4 and NaV1.8 
were successfully expressed when co-transfected with auxiliary NaVβ1-subunit. The 2004 
report highlighted the higher toxin concentrations, in the μM range, needed to give 
electrophysiological responses, when low nM range were found to be effective in previous 
studies, suggesting that a unique channel conformation due to the presence of other proteins 
not provided in HEK cells such as auxiliary subunits could be responsible for channel higher 
sensitivity to the toxin. In an earlier study using TSA 201 cells transiently transfected with the 
rat NaV1.2 α with the NaVβ1 subunits, the binding for both brevetoxin and saxitoxin was 
found directly related to the molar ratio of β1 to α subunit (Trainer et al., 1996).  
In heterologous expression systems, host cell do not always provides proteins essential 
for function or stability, i.e. chaperone, anchoring proteins, scaffold proteins for intracellular 
signalling (Thomas and Smart, 2005; Holst et al., 2009). The importance of the auxiliary β-
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subunits in the expression and stabilization of NaV α-subunit in the membrane as well as their 
role as structures of contact with cytoskeletal or extracellular matrix proteins have been well 
demonstrated (Moran et al., 2003). However no mRNA for subunit β1 has been found in HEK 
cells (Moran et al., 2000; Young and Caldwell, 2005), and although abundant mRNA 
encoding for the NaV auxiliary NaVβ2, NaVβ3, NaVβ4, NaVβ1A and NaVβ1B splice variants 
(Moran et al., 2000; Shah et al., 2004; Young and Caldwell, 2005), and very low levels of 
NaVβ1 and NaVβ2 subunits (Shah et al., 2004) were reported, recent Western blots analyses 
(Aman et al., 2009) found no detectable expression of NaVβ1A, NaVβ2, NaVβ3 and NaVβ4. 
The lack of cofactors such as β-subunits in HEK heterologous expression system could lead to 
missing interactions and altered channel conformation in a region important for toxin 
sensitivity (Moran et al., 2003, Kamiya et al., 2004; Yamaoka et al., 2009). This may be the 
case particularly for NaV1.8 which is mainly localized intracellularly in the cytoplasmic pool 
and has to be recruited to the plasma membrane to exert its function (Djouhri et al., 2003).  
 
Conclusions 
The present study compared the potency of several ciguatoxins (P-CTX-1; C-CTX-1; P-CTX-
3C) and brevetoxins (PbTx-1, PbTx-7, PbTx-3) on human voltage-gated sodium channel of 
either central NaV1.2 or peripheral NaV1.8 nervous system expressed in HEK cells. 
High level of NaV mRNA were found in the HEK clones and a dose-dependent cytotoxic 
effect of the polyether toxins confirmed the presence of functional NaV proteins at the cell 
membranes. 
The peripheral as well as the central sodium channel isoforms were similarly susceptible to 
site-5 toxins. 
A better understanding of the specific neurologic in particular cutaneous effect of the 
ciguatoxins may require further investigation of NaV1.9 or NaV1.6 susceptibility. 
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